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GENERAL INTRODUCTION 
"The constancy of the 'milieu Interleur' Is the condition of free and 
Independent existence." -Claude Bernard, 1878. 
The environmental stress that Is placed on an animal can evoke a 
range of response from minor stimulation to total exhaustion. In 
1878, Claude Bernard described the "milieu intérieur" of an animal, 
characterized by its constancy, and the external environment, 
characterized by its variability. This was a first description of the 
response of an animal to environmental stimuli. For the past 8000 years 
the "milieu interleur" of animals have been somewhat threatened due to 
the continuing practice of animal domestication. Domestication has been 
sucessful due to the ability of the animal to tolerate humans, to have a 
non-migratory nature, catholic food preferences and to adapt to a wide 
range of environments (Hale, 1969). An animal's degree of adaptability 
is challenged by changes in metabolism brought about by interactions 
between the animal and humans. Endocrine and neuropeptide factors 
ellcted during a response of an animal toward environmental stress may 
ultimately affect the Immune system to produce Immunoenhancement, 
immunosuppression or have no effect. If we are to understand the impact 
of environmental stimuli on disease susceptibility, a proper 
understanding of the response of animals exposed to conditions of 
management or stress is necessary. 
If stress-induced immunosuppression in livestock can be related to 
disease problems, then methods modulating the immune response should 
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benefit the animal. One approach to this problem is to give the animal 
substances that can augment the host defense mechanisms and, therefore, 
Increase disease resistance. Substances which have the capability of 
regulating or modulating host defense mechanisms are termed 
immunomodulators. An effective immunomodulator Is needed to relieve 
Immunosuppression resulting from stress and thus, Increase the animal's 
resistance to disease and Infection. 
The association between nutrition and disease has been well 
recognized. For many decades, Investigators around the world have 
recognized that deficiencies or excesses of some dietary components lead 
to enhanced susceptibility to Infection and disease. Studies of 
nutrition and Immunocompetence were stimulated by the description of 
Kwashiorkor, observed by Cicely Williams In 1931 and 1932 In Infants and 
young children In Africa. This observation has led to the possibility 
that Immune defects observed in protein-calorie malnutrition may result 
from deficiencies or excesses of essential amino acids. In addition to 
the effect that total amount and quality of protein has on the immune 
response, excessive or deficient concentrations of specific amino acids 
in the diet appear to have an effect on immunity. Tryptophan (Koyanagi 
and Ishlguro, 1966) and phenylalanine (Ryan and Carver, 1964) must be 
present in adequate dietary amounts for optimal production of antibodies 
and reticuloendothelial system clearance functions. Branched-chain 
(leucine, isoleuclne and valine) and sulfur-containing (methionine, 
cysteine and cystine) amino acid deficiencies have adverse effects on 
the spleen, lymph nodes, thymus and gut lymphoid tissues (Beisel, 1982; 
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Gross and Newberne, 1980). Inununosuppresslon Is observed In rats fed an 
overload of leucine if they are on a protein Inadequate diet (Chevalier 
and Aschkenasy, 1977). This suggests that a balanced amino acid intake 
(quality), as well as total amount (quantity), is important. 
The use of dietary protein and amino acids as immunomodulators has 
not been studied extensively, although it is clear that these dietary 
components affect the immune system. It has been well documented that 
dietary proteins and amino acids interact in leucopoiesis regulation 
(Aschkenasy, 1975). They can act directly as building blocks or 
Indirectly either by influencing the secretion of hormones capable of 
interfering with leucocyte production (e.g., glucocorticoids) or by 
influencing immunological reactions which mostly involve lymphocytes, 
macrophages and granulocytes. 
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REVIEW OF THE LITERATURE 
ImmunomodulatIon 
Inununomodulatlon describes the pharmacological manipulation of the 
active state of the immune system. This may involve immunostimulatlon 
which is an enhancement of the host defense mechanisms, or 
immunosuppression which results in a decrease in the host defense 
mechanisms. Immunomodulators are therefore, substances that have the 
capacity to regulate or modulate the host defense mechanism. 
Immunomodulators are classified according to their origin and 
categorized as biological products or chemical immunomodulators (Poll, 
1984). This classification can be further broken down into three 
subcategories: physiological products (e.g., thymic factors and 
glucocorticoids) substances of microbial origin (e.g., cyclosporin A and 
lentinan) or synthetic compounds (e.g., levamlsole and isoprlnoslne). 
Many theories of Immunomodulator action have been proposed. 
Actions Include the inhibition of prostaglandin synthesis (Nlshiya and 
Horwitz, 1983), altering of Intracellular cAMP/cGMP (Coffey and Hadden, 
1985), blockage of DNA synthesis (Hinrichs et al., 1983) and interferon 
Induction (Woodard et al., 1983). Of these proposed mechanisms it is 
most often possible to relate changes in immunologically active cells to 
cyclic nucleotide levels. Many immunosuppressive compounds have been 
shown to increase cAMP, for example glucocorticoids and prostaglandins 
of the E series. Those compounds with Immunostimulatory effects 
Increase cellular cGMP such as the thymic hormone thymopoeltln, 
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Interleukln-1 and plant mitogens. In general, Increased cGMP in 
lymphocytes is associated with increased activity and increased cAMP is 
associated with suppressed activity. The action of many 
immunomodulators can therefore be associated with changes in cAMP:cGMP 
in cells. 
Immunomodulation has been used extensively in human subjects for 
cancer therapy, alleviation of autoimmune conditions and facilitation of 
organ transplantation. Immunomodulation is also used extensively to 
increase non-specific resistance to infection in farm animals. This is 
done with the aim of minimizing the deleterious effects of the less than 
optimal environmental conditions imposed by modern Intensive 
agricultural practices. Many feed additives are added to livestock 
diets in the hopes of increasing resistance to disease and infection. 
For example, an antioxidant, butylated hydroxytoluene (BHT), is often 
added to poultry feeds and has been shown to exert an immunoenhancing 
effect in that it is correlated with increased resistance of chickens 
against Newcastle disease virus infections (Brugh, 1977). Other feed 
additives such as vitamins A (Stern et al., 1980) and E (Reddy et al., 
1986) have been shown to enhance the immune system in vivo and in vitro. 
Another compound, Glucan, a particulate ^ -1,3 polyglucose prepared 
from Saccharomvces cerevisiae. has been shown to elicit a broad spectrum 
of immunobiological activities against infectious diseases in a variety 
of experimental animals. These activities Include; the enhancement of 
macrophage phagocytic function (Riggi and Di Luzio, 1961), increased 
cellular and humoral immunity (Wooles and Di Luzio, 1962, 1963, 1964) 
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and enhancement of antigen clearance (D1 Luzlo and Morrow, 1971). 
Two commonly used anthelmintics in cattle, sheep and pigs, 
levamisole and thiabendazole, have been studied widely as 
Immunomodulators (Brunner and Muscoplat, 1980). Although these 
compounds produce positive immunomodulating effects in some studies, it 
appears that the dosage and time of administration relative to 
stressful. Immunosuppressive stimuli restrict their use in stressed 
livestock. Another compound studied, sodium dlethyldithiocarbamate 
(imuthiol; a biological respone modifier which influences T-lymphocyte 
function), also has been shown to exert immunostimulatlng effects 
(Renoux and Renoux, 1984). The use of this product is also limited in 
domestic food-type animals, since a reduction in growth is observed. 
Other Immunomodulating exogenous substances such as avrldlne (CP 20,961; 
a llpoldal amine that has activity as an interferon Inducer), 
Isoprlnoslne (an Inoslne-containing compound used to enhance cell 
mediated immunity) and cytokines (e.g. interferons and interleuklns) have 
also been investigated. 
Since the use of some Immunomodulators may inflict adverse effects 
such as reduction in growth rate or inflammation, limitations exist in 
their therapeutic application. These limitations can be summarized as 
follows; (1) the effects of Immunomodulators may not be specific to 
particular cell subsets or types ; (2) inappropriate dosage can produce 
undesirable results; (3) the timing of the Immunomodulator 
administration is critical; (4) individual variation is commom; (5) 
side-effects are common; (6) the long-term effects are unknown (Mulcahy 
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and Qulnn, 1986). 
Stress-Induced Immunosuppression 
Modern day management of livestock entering feedlots often results 
In stress which has been shown to be associated with Immunosuppression. 
This effect may at least partially account for the animals Increased 
susceptibility to a variety of pathogens and subsequently the 
development of disease and Infection. As early as 1878, animals 
responses toward stress were realized as Claude Bernard described the 
"milieu Interleur" of an animal. In 1914, Cannon further defined this 
concept as 'homeostasis'. In which a steady state Is attained by the 
optimum Interaction of counteracting processes within the host. Cannon 
(1929) also defined the 'flight-fight' reflex of animals exposed to 
stress and Identified the damaging effects this may have In the 
Individual. In 1935, Cannon presented new evidence showing that the 
physiological basis of the stress response was due to the activation of 
endocrinological factors involving the sympathetic adrenomedullary axis. 
Then in 1946, Selye used the response of laboratory animals exposed to 
experimentally noxious stimuli to describe the 'general adaptation 
syndrome' (GAS). Because different stimuli produced the same response, 
involving the pituitary-adrenal-cortical axis, he concluded that the 
response to stress was non-specific. Selye also concluded that stress 
Involved the non-specific production of corticosteroids, and that the 
measurement of glucocorticoids could be used as the primary indicator 
of stress and the animal's well being. This concept was disputed by 
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Mason (1968), who showed that different types of stress produce 
different corticosteroid levels In monkeys. He explained that there 
exists different responses unique for each stressor and that the 
activation of the autonomic adrenomedullary reponse as well as the 
pituitary adrenocortical response occurred. It is now widely accepted 
that there are different endocrine responses to different physical, 
chemical and physiological stressors, and these responses vary within 
and among different species of animals (Dantzer and Mormede, 1985). 
As was first decrlbed by Harris (1948), a major response of the 
body to stress is the stimulation of the hypothalamus which liberates 
corticotropin-releasing factor which further stimulates the anterior 
pituitary gland to secrete adrenocortlcotroplns (ACTH). The target 
organ affected by ACTH is the adrenal cortex. Cortical cells of the 
adrenal glands then synthesize and release glucocorticoids 
(cortisol/corticosterone) into the blood. Glucocorticoids are believed 
to have their dominant effect on the Inflammatory and immunological 
systems, usually by exerting suppressive effects. 
In many species glucocorticoid production is associated with 
adrenal hypertrophy, thymic involution, lymphocytopenia, eoslnopenla and 
neutrophilia (Selye, 1946; Jensen, 1969; Riley 1981; Cupps and Fauci, 
1982). Glucocorticoid administration markedly Increases the animal's 
susceptibility to infectious disease and can cause activation of latent 
Infection. In cattle glucocorticoid injections decrease resistance to 
infectious bovine rhlnotracheltls virus (Davles and Duncan, 1974), fatal 
bovine viral diarrhea virus (Shope et al., 1976) and parasites (Callow 
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and Parker, 1979). Reduced levels of humoral immunity may also result 
from the administration of glucocorticoids to cattle (Gwazdauskas et 
al., 1978). A reduction of in vitro lymphocyte blastogenesis and 
neutrophil function was also seen in cattle which were treated with 
ACTH so that their blood glucocorticoid concentrations were elevated 
(Roth et al., 1982). 
The systemic administration of corticosteroids has also been shown 
to depress the circulation of lymphocytes from lymph nodes. In sheep, 
the glucocorticoid methyprednisolone, given intravenously reduces the 
output of lymphocytes into the efferent lymph to between 16-22% of pre-
administration levels (Zukoski and Montgomery, 1983). The number of 
lymphocytes in the lymph and blood is therefore decreased. The 
circulation of lymphocytes from blood to lymph is believed to be 
important for the selective recruitment of antigen-specific lymphocytes 
to a responding lymph node (Cahill et al., 1974), hence, the magnitude 
of the subsequent immune response may be inhibited. This decrease in 
lymphocytes is accompanied by a parallel increase in blood granulocytes 
and monocytes. These changes in sheep are kinetically and qualitatively 
similar to those seen in man, but are somewhat more exaggerated (Parrlllo 
and Fauci, 1979). It has also been shown that sheep efferent lymph 
cells are extremely resistant to glucocorticoid-Induced lysis in vitro 
and require glucocorticoid levels 2-4 log doses higher than those needed 
in murine systems to lyse the cells (Zukoski and Montgomery, 1985) 
which are about the same concentration as those needed for human cell 
lysis (Claman et al., 1971). Sheep therefore appear to be a "steroid 
10 
resistant" species like man, monkeys and guinea pigs (Claman, 1972). 
Monoclonal Antibodies to T-cell Subsets 
In 1975, George Kohler and Cesar Mllsteln combined B-cells from 
Immunized animals with neoplastic myeloma cells and thus, developed 
hybrldomas secreting monoclonal antibodies. This monumental achievement 
was made possible by a number of unrelated discoveries of other workers. 
Contributing to the development of monoclonal antibodies was the clonal 
selection theory (Burnet, 1957), the development of cell fusion 
techniques (Okada, 1962; Llttlefleld, 1964), the artificial Induction of 
plasmacytomas (Potter and Boyce, 1962), their adaption to tissue culture 
(Horlbata and Harris, 1970) and the demonstration of the fusion of two 
different plasma cell tumor lines (Cotton and Mllsteln, 1973). 
Prior to the 1950's the concept of how antibodies were produced in 
response to antigens was unknown. In 1957, F. Macfarlane Burnet 
hypothesized the clonal selection theory. It postulated that each 
lymphocyte has a unique receptor specificity and was precommitted to 
making only one antibody after antigenic stimulation. Evidence in 
support of this theory was provided by Nossal and Lederberg (1958), who 
showed that a single antibody producing cell in rats immunized with two 
antigens, produced antibodies in response to only one of the antigens. 
The clonal selection theory remained in question until the Cold Spring 
Harbor Conference of 1967 in which this theory was finally accepted. 
In the 1970's, Cesar Mllsteln had been interested in the genetic 
control of antibody synthesis. In a study he was performing, hybrids 
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between rat and mouse myeloma cells were constructed and It was shown 
that the synthesis of both species of Immunoglobulins produced was 
retained but mixed molecules were formed (Cotton and Mllsteln, 1973). 
The Induction of myeloma (tumor) cells In mice was described by Potter 
and Boyce in 1962. The development of these cells has been responsible 
for much of our current knowledge of immunoglobulin structure, 
biosynthesis and genetics. 
In a subsequent experiment in which somatic mutation in antibody 
genes was being investigated through the use of a mouse myeloma cell, it 
was shown that a high degree of instability in immunoglobulins existed 
(Cotton et al., 1973). A way of constructing continuous cell lines 
secreting antibody of a known specificity was needed. In 1975, Kohler 
and Mllsteln extended their previous experiments and fused a mouse 
myeloma cell with an antibody producing spleen cell from a mouse 
immunized with sheep red blood cells. The experiment worked as planned 
and cloned hybrid lines secreting anti-sheep red blood cell antibodies 
were produced. These cells were capable of forming tumors when Injected 
Into mice. These tumors are now known as "hybridomas". When hybridomas 
are injected Intraperltoneally into mice, a large volume of ascites 
fluid builds up and this fluid is rich In monoclonal antibodies. 
This was a revolutionary discovery. Unlimited quantities of 
absolutely specific and uniform antibodies recognizing only one 
antigenic site were produced. Since this time. Improvements have been 
made in cell fusion and screening techniques, and monoclonal antibodies 
specific for various cell types and cell products are becoming readily 
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available. 
It has been demonstrated that a high degree of evolutionary 
conservation exists among species in lymphocyte surface antigens. A 
great deal of homology in molecular size and tissue distribution is seen 
between the human T-cell subset monoclonal antibodies T4 and T8 and 
those markers for the same subsets in the rat and mouse (Ledbetter et 
al.,1981; Dialynas et al., 1983; Mason et al., 1983). In all three 
species these markers have been shown to be coexpressed on cortical 
thymocytes and exclusively expressed on medullary thymocytes and 
peripheral lymphocytes. These markers distinguish functionally distinct 
populations of T-cells. T4 markers distinguish T-helper cells which 
recognize antigens in association with major histocompatibility complex 
class II molecules, and T8 markers which recognize antigens in 
association with major histocompatibility complex class I molecules. 
Recently, monoclonal antibodies have been used to identify functional 
lymphocyte subsets in man (Lanier et al.,1983), mouse (Swain ,1983), rat 
(Mason et al., 1983), swine (Jonjic and Koszinowski, 1984), rabbit 
(Watkins et al., 1984) and some other species. 
Currently, extensive research on lymphocytes in sheep is possible 
due to the existence of monoclonal antibodies specific for sheep T-
lymphocyte subsets. Studies can now be conducted on lymphocyte 
recirculation, fetal lymphoid development and immunological alterations 
caused by various chemical or naturally occurring compounds in sheep. A 
panel of monoclonal antibodies specific for sheep T-cell surface 
antigens has been developed (Mackay et al., 1985; Maddox et al., 1985; 
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Mackay et al., 1986). Two of these monoclonal antibodies define the 
sheep T4 and T8 antigens, a third monoclonal antibody defines a T-cell 
antigen not previously identified in any other species. There is also 
monoclonal antibody available which identifies total sheep T-
lymphocytes. Table 1 and 2 summarize the properties of these sheep T-
lymphocyte monoclonal antibodies. 
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Table 1. Properties of sheep lymphocyte antigens recognized 
by monoclonal antibodies 
Antibody 
designation 
















(Summarized from Gorrell et al., 1986) 
Table 2. Percent of mononuclear cells reacting with sheep monoclonal 
antibodies derived from various sheep lymphoid tissues 
Source of mononuclear cells 
Antibody Peripheral Lymph 
designation blood Lymph nodes Thymus 
SBU-Tl 62 74 62 98 
SBU-T4 20 49 37 81 
SBU-T8 12 18 21 77 
SBU-T19 15 7 2 1 
(Summarized from Mackay et al., 1986) 
15 
Leucine and Leucine Metabolites 
General metabolism Leucine (Leu) Is a ketogenlc branched-chain 
essential amino acid (BCAA). The sources of Leu Include protein 
breakdown, dietary Leu or the transamination of Its a-ketoacld, a-
ketolsocaproate (KIG). Leu can be reverslbly transamlnated to KIC via 
the enzyme BCAA transaminase. KIC then enters the mitochondria and can 
be irreversibly oxidized to isovaleryl CoA (IVACoA) by the enzyme, 
branched-chain ketoacld (BGKA) dehydrogenase. However, KIG can also be 
converted to ^ -hydroxy-^ -methylbutyrate (HMB) by KIG oxygenase in the 
cytosol of the liver. The product, HMB, is believed to be an end 
product excreted in the urine. 
IVAGoA can be further metabolized In the mitochondria to 
j8-methylcrotonyl GoA, then to /8-methylglutaryl GoA and finally to 
-^hydroxy-p-methylglutaryl GoA (HMGCoA). HMGGoA can then be metabolized 
by HMG cleavage enzymes to acetoacetate plus acetyl CoA. Acetoacetate 
can then be converted to acetoacetyl GoA and HMGGoA or to ^ -hydroxybutyrate 
(BOHB). HMGGoA can be further metabolized to melvalonlc acid which 
ultimately is converted to cholesterol and other steroids. 
Immunological effects Feeding excess Leu has been demonstrated to 
adversely affect Immune response. A dietary Leu overload (3% of dry 
weight of the diet for 2 weeks and 7% for 6 weeks) has been shown to 
cause a decrease in the production of rosette and plaque forming cells 
in the spleen and also to decrease the titer of serum antibodies in rats 
against sheep red blood cells (Chevalier and Aschkenasy, 1977). These 
suppressive effects became dramatic when the rats were subjected to a 
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low protein diet and Leu was then supplemented. Excess dietary Leu is 
known to induce a secondary drop in plasma concentrations of Isoleucine 
and valine (Benton et al., 1956; Tannous et al., 1966). This drop in 
plasma concentrations may be due to an excessive activation of enzymes 
of the catabollc pathway of BCÂA (Ichlhara and Koyama, 1966). A lack of 
Isoleucine and valine has been shown to lead to an inhibition of 
leucopoiesis (granulocytes and lymphocytes), with involution of the 
lymphoid organs, especially the thymus, and a dramatic drop in blood 
lymphocyte levels (Aschkenasy, 1975). Since a close relationship exists 
between lymphocytes and immunity, a suppressive effect on Immunity is 
therefore induced by feeding excess leucine. 
Rats fed a protein poor diet supplemented with excess Leu 
completely supressed immunoglobulin G production after Immunization with 
sheep red blood cells (Chevalier and Aschkenasy, 1977). In a similar 
study in which chickens were fed diets supplemented with 3 levels of 
Leu, primary and secondary antibody responses to sheep red blood cells 
were depressed (Tinker and Gous, 1986). This study also measured a 
depression in primary and secondary serum immunoglobulins M and G. 
Lastly, Leu was also found to be immunosuppressive when fed to sheep in 
small amounts (Kuhlman et al., 1988). When ruminally by-passed Leu was 
fed to growing lambs at a rate of approximately 0.05% of the diet, 
antibody production to porcine red blood cells and ConA stimulated 
lymphocyte blastogenesis was depressed. 
Other derivatives of Leu have also been shown to exert 
immunodepressive effects. It has been shown that L-leucyl-L-leucine 
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methyl ester, which is generated by human monocytes or polymorphonuclear 
leukocytes, eliminates all natural killer cell function from mixed 
lymphocyte populations (Thiele and Lipsky, 1985). It seems to have 
selective toxicity for natural killer cells, monocytes and various 
cytotoxic T cells but does not adversely effect other lymphoid or 
nonlymphoid cell types when incubated with human peripheral blood 
mononuclear cells in tissue culture (Thiele and Lipsky, 1986). Similar 
results have been seen in murine spleen cell cultures (Thiele et al., 
1987). 
Another derivative of Leu, cycloleucine, has been shown to inhibit 
primary immune responses to sheep red blood cells and allograft 
reactions when Injected intraperitoneally to mice (Brambllla et al., 
1972). In 1969, Frlsch reported that in mice very high doses of 
cycloleucine prevent the synthesis of hemagglutinins and hemolysins for 
sheep erythrocytes by reducing the number of plaque-forming cells of the 
spleen (Frlsch, 1969). Cycloleucine has since been used therapeutically 
as an anticancer drug (Carter, 1970). 
The effects of the first catabollc product of Leu, KIC, on Immune 
function have also been studied. When ruminally by-passed KIC was 
orally administered to sheep, an increase in antibody production to 
porcine red blood cells and lymphocyte blastogenesls was seen (Kuhlman 
et al., 1988). Other studies have shown that the oral supplementation 
of KIC to sheep for 8 weeks results in a two-fold increase in FHÂ 
stimulated lymphocyte blatogenesis (Nissen et al., 1986). The 
enhancement effect on Immune function observed with the oral 
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supplementation of KIC, may be due In part to an Increase of T-helper 
cells In these animals (Kuhlman et al., 1989). In this same study, the 
effects of Isovalerate, a metabolite of Isovaleryl CoA, was shown to 
have no effect on antibody production or lymphocyte blastogenesls when 
fed to growing lambs. 
Other studies have evaluated the effects of acetone, acetoacetate, 
BOHB and butyrate on bovine lymphocyte blastogenesls in vitro and in 
vivo. In one study, bovine lymphocytes were cultured in the presence 
of toxic and subtoxic concentrations of these compounds ranging from 1-
50 mg/dl (Targowskl and Kluclnskl, 1983). Toxic and subtoxic 
concentrations of BOHB and toxic concentrations of butyrate and acetate 
significantly reduced the mltogenic response of the bovine lymphocytes. 
The reduction in mltogenic response also occurred when the lymphocytes 
were prelncubated with BOHB or acetoacetate for 2 hours or longer. The 
presence of toxic concentrations of acetone in the medium did not affect 
the mltogenic stimulation of the lymphocytes. In a subsequent experiment, 
cattle were made ketotic by the addition of 1,3 butanediol so that the 
blood concentrations of these compounds were elevated (Targowskl et al., 
1985). The mltogenic response of lymphocytes collected during this 
ketotic period was significantly suppressed and remained supressed for 2 
weeks. During this time period, all calves made ketotic showed clinical 
signs of upper respiratory Infections. It was hypothesized that a 
correlation may exist between the suppressed function of lymphocytes, 
the Increased susceptibility of the calves to Infection and the 
Increased concentrations of the Leu metabolites in the blood. 
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EXPLANATION OF DISSERTATION FORMAT 
This dissertation is presented in the alternate format, as outlined 
in the Iowa State Graduate College Thesis Manual. Use of the alternate 
format allows for the preparation of independent sections that are 
suitable for submission to scientific journals. 
Three separate papers have been prepared from the data collected 
from research performed to partly fulfill requirements for the Ph.D. 
degree. Each paper is complete in itself and has an abstract, 
introduction, materials and methods, results, discussion and literature 
cited section. The closeness of the subject matter of the three papers 
allowed a general discussion to be prepared. 
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ANIMAL CARE 
The animals used in the following trials were treated In accordance 
with the Iowa State University animal care guidelines. 
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SECTION I. MODULATION OF T-CELL SUBSETS IN SHEEP BY DIETARY 
LEUCINE AND a-KETOISOCAPROATE 
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Leucine (Leu) and Its ketoacld, a-ketolsocaproate (KIG), have been 
shown to exert opposing effects on antibody production and lymphocyte 
blastogenesls when orally administered to sheep. Two experiments were 
conducted to determine whether these effects are associated with 
alterations In the percentage of circulating T-cell subsets or to 
hormonal changes within the animal. Mitogen stimulated lymphocyte 
blastogenesls and flow cytometric analysis of Tl, T4, T8 and T19 
lymphocyte subsets were determined. Serum Cortisol, Insulin and 
glucagon concentrations were also evaluated. In both experiments, 
feeding KIC resulted In Increased lymphocyte blastogenlc responsiveness 
to phytohemmagglutlnln-P (PHA) and pokeweed mitogen (PWM) comparing KIC-
fed animals to controls (P < 0.05). Feeding Leu significantly decreased 
responses to all three mitogens compared to KIC fed animals (P < 0.05) 
and tended to decrease mltogenlc responses when compared to controls. 
When KIC was fed, the percentage of circulating T4 cells were 
significantly Increased (P < 0.05). Leu fed animals had a significantly 
lower percentage of circulating T19 cells (P < 0.05). No significant 
differences were seen In serum hormone concentrations. These data 
Indicate that the opposing effects exerted by Leu and KIC on various 
Immune functions are associated with and may be due to alterations In T-
lymphocyte subsets. 
(Key words: Leucine, o-Ketolsocaproate, T-Lymphocytes, Blastogenesls) 
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INTRODUCTION 
Previous studies Indicate that the oral supplementation of leucine 
(Leu) to sheep decreased serum antibody response to porcine red blood 
cells and decreased mitogen-stimulated lymphocyte blastogenesls, 
however, the first catabolic product of Leu, o-ketolsocaproate (KIC), 
enhanced the antibody response to porcine red blood cells and increased 
mitogen stimulated lymphocyte blastogenesls (Kuhlman et al., 1988). The 
reasons for the opposing effects of Leu and KIC may involve their 
different sites of metabolism. Leu is primarily metabolized by the 
peripheral tissues (Bergman, 1986) and KIC is primarily metabolized by 
the liver and gut (Abumrad et al., 1982; Pell et al., 1986). Thus, the 
gut and liver associated lymphoid tissues would be exposed to high 
concentrations of KIC and/or KIC metabolites while the peripheral 
lymphoid tissues would be exposed to high Leu metabolite concentrations. 
This difference in the site of metabolism combined with the very low 
rate of Leu-KIC interconversion in sheep (Busboom et al., 1984; Nissen 
and Ostaszewski, 1985) could explain why KIC results in different 
metabolic effects than Leu. 
The mechanism by which KIC and Leu could actually alter 
blastogenesls and antibody production is not clear. One possibility may 
be that KIC is altering the ratio of certain T-cell subsets in a manner 
that would enhance such immune responses, while Leu is altering the 
ratio of certain T-cell subsets such that antibody production and 
lymphocyte blastogenesls are lowered. Other possible mechanisms may 
involve alterations in the secretion of or responsiveness to 
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lnterleukln-2 (T-cell growth factor), or hormones such as Cortisol 
(which has been shown to be Immunosuppressive; Farrlllo and Fauci 1979), 
glucagon and Insulin (both can be affected by Leu and KIC and affect 
protein synthesis; Leclercq-Meyer et al., 1979) could be altered. 
The objectives of the studies reported here were: (1) to confirm 
the effects of Leu and KIC seen previously on lymphocyte blastogenesis, 
(2) to determine whether the oral administration of small doses of Leu 
and KIC can alter the proportions of circulating T-cell subsets In 
lambs, and (3) determine if hormonal changes occur and if these changes 
could be responsible for the alterations of lymphocyte blastogenesis 
caused by Leu and KIC. 
33 
MATERIALS AND METHODS 
Animals and Experimental Design. Two separate experiments 
were conducted using 21 mixed-breed ram lambs In the first experiment 
and 24 mixed-breed ewe lambs In the second experiment. Animals were 
allowed free access to water throughout the study and housed 
2 Individually In fiberglass pens (1.15 m ). Animals were randomly 
assigned to one of three dietary treatments: Leu (n-15), KIC (n-15) or 
limestone (control; n-15). Feed consumption was recorded and animals 
were weighed at the beginning and at the end of the 46-52 d studies. 
Diets. The diets fed to the sheep In experiment 1 and experiment 2 
are shown in Table 1. Diets were formulated using the metabollzable 
protein system (Burroughs et al., 1975) and contained approximately 70 
g metabollzable proteln/kg. Dietary treatments were supplemented to the 
basal diet (Table 1) In the form of zeln coated pellets whose 
composition and method of preparation have been previously described 
(Kuhlman et al., 1988). Lambs were fed their respective pellets at a 
rate of approximately 3 g/d, which corresponds to approximately 5 mmol 
of LEU or KIC per total kg of diet. Leu was purchased from Sigma 
Chemical, St. Louis, Mo. KIC was purchased as calciim-(KIC)^  from 
SOBAC, Paris, France and 325 mesh limestone was purchased from Iowa 
Limestone, Des Moines, Iowa. 
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kg Dry Matter 
1 Experiment 2' 
Ground corn 
Dehydrated alfalfa 


















 ^Formulated to contain 1.9 Meal net energy/kg for maintenance, 
1.3 Meal net energy/kg for gain, 10.6% crude protein, 70.98 g 
metabollzable proteln/kg and 87% dry matter. 
2 Formulated to contain 1.7 Meal net energy/kg for maintenance, 
1.2 Meal net energy/kg for gain, 16% crude protein, 68.64 g 
metabollzable protein/kg and 88.5% dry matter. 
3 Purchased from West Central Cooperative, Ralston, IÂ. 
 ^Purchased from Feed Specialties Co., Des Moines, lA. Contains 1.64% 
Mg, 4949 mg Mn/kg, 371 mg Zn/kg, 2600 mg Fe/kg, 0.05 mg Cu/kg, 47.4 
mg Co/kg, 128 mg I/kg, 25 mg Se/kg, 3.25% S, 772727 USP Units 
vitamin A/kg, 102273 USP Units vitamin D3/kg, 773 lU vitamin E/kg. 
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Blood Sampling and Lvmphocvte Preparation. In the first experiment, 
animals were bled for lymphocyte blastogenesis assays and T-cell subset 
analysis 38, 45 and 52 d after dietary treatments began. In the 
second experiment, animals were bled 14, 33 and 46 d after dietary 
treatments began. Blood (50 ml) was collected, aseptically, via jugular 
venapuncture into 10 ml acid-citrate-dextrose anticoagulant (44 g 
trisodium citrate, 16 g citric acid and 50 g dextrose per 1 of triple 
distilled water). Blood was centrifuged, the buffy coat removed, and 1 
volume of buffy coat was diluted with one half volume of plasma and was 
added to 2 volumes of Sepracell-MN (Sepratech Corporation, Oklahoma 
City, OK). After further centrifugation at 1500 x g for 25 min, the 
mononuclear layer was removed and washed twice with Hanks' balanced salt 
solution (HBSS; Gibco, Grand Island, NY) by centrifuging at 150 xg for 
15 min. The remaining white blood cells were resuspended in HBSS and 
the total number of white blood cells were determined using an automated 
cell counter (Coulter Electronics, Hialeah, FA). The concentration of 
the cells was adjusted to 1 x 10^  cells/ml with HBSS. 
Lvmphocvte Blastogenesis Determinations. Blastogenesis assays were 
performed on isolated lymphocytes by using a 3-d culture procedure as 
described previously (Roth et al., 1982). Briefly, isolated lymphocytes 
were cultured in microtiter plates with 2 x 10^  cells in 0.15 ml of 
culture medium/well. Culture medium consisted of RPMI media-1640 
(Gibco, Grand Island, NY) containing 15% heat-inactivated fetal bovine 
serum and 1% antibiotic-antimycotic solution (Gibco, Grand Island, NY). 
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Unstimulated and mitogen stimulated cultures were assayed In triplicate. 
Mitogens used were phytohemagglutlnln-2 (PHA), concanavalln A (ConA) and 
pokeweed mitogen (FWM). PHA was purchased from Dlfco Laboratories, 
Detroit, MI; ConA from Miles Laboratories, Elkhart, IN; and PWM from 
Glbco, NY. Mlcrotlter plates were Incubated at 37° C In a humidified 5% 
3 COg atmosphere. After 48 h, 0.25 uCl of H-thymidine (New England 
Nuclear, Boston, MA) was added to each well. Eighteen h later, the 
cultures were harvested onto glass-fiber filters with an automated 
sample harvester (Flow Laboratories, Rockvllle, MO), filters were placed 
In 10 ml CytoSclnt scintillation solution (ICN Biomedicals, Irvine, CA) 
and radioactivity was counted In a liquid scintillation counter. 
Antibodies. A panel of monoclonal antibodies directed against sheep 
T-lymphocyte surface determinants (Table 2) was used. Monoclonal 
antibodies. In the form of cell-free culture supematants were obtained 
from Dr. M.R. Brandon, University of Melbourne, Farkvllle, Victoria, 
Australia. Additional properties of the antigens recognized by the 
monoclonal antibodies have been reviewed elsewhere (Mackay et al., 1985 
and 1986; Maddox et al., 1985). A fluorescelnlsothlocyanate-conjugated 
rabbit F(ab')2 anti-mouse Immunoglobulin (FITG-RAM) was purchased from 
DAKO Corporation, Carplnterla, CA. Monoclonal antibodies SBU-T4, T8 and 
T19 were used in both experiments. Monoclonal antibody SBU-Tl was used 
in experiment 2 only. 
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of target antigen 
Human/murine 
analogue 
Percentage of stained 
peripheral lymphocytes 
SBU-Tl 67,000 Tl/Lyl 60-80 
SBU-T4 56,000 T4/L3T4 20-50 
SBU-T8 36,000 T8/Ly2 10-20 
SBU-T19 215,000 ? 15 
Inununofluorescent Staining. Sheep lymphocytes (10*) in 50 ul 
phosphate-buffered saline, 0.1% sodium azlde (PBS/Az), 0.5% BSA were 
incubated for 30 min at 4° C with 50 ul monoclonal antibody culture 
supernatant. Additionally, cells were incubated with monoclonal 
antibody culture supernatant only and with FITC-RAM only so that any 
nonspecific fluorescent staining could be determined. Nonspecific 
labelling averaged approximately 1-2% so was not considered an important 
variable in this study. The cells were washed twice with PBS/Az by 
centrifuglng at 150 x g for 15 min and Incubated with 40 ul of FITC-RAM 
for 30 min at 4° C. Cells were washed 3 times with PBS/Az, resuspened 
in 200 ul 1% formalin and stored overnight at 4° C until analyzed. 
Flow Cytometric Analysis. Fluorescent stained cells were detected 
using an EPICS 752 flow cytometer (Coulter Electronics, Hlaleah, FA). 
Light passing to the fluorescence detector was split using a 488 nm 
dlchrolc filter. FITC fluorescence was collected through a 515 long 
pass filter and the presence or absence of a range of cell surface 
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markers was determined. Only cells containing the lymphocyte 
populations indicated by the forward angle light and 90° light scatter 
histogram were analyzed for fluorescence using the EASY88 computer 
system with Intgra software (Coulter Electronics, Hialeah, FL). A 
minimum of ten thousand events were collected per sample. All data are 
presented as percent positive cells. 
Determination of Serum Cortisol. Glucagon and Insulin 
Concentrations. Serum Cortisol and insulin concentrations were 
determined by coated tube single antibody radioimmunoassay using 
commercial kits (Diagnostic Products Corporation, Los Angeles, CA). 
Serum glucagon concentrations were determined using a double antibody 
radioimmunoassay kit (Diagnostic Products Corporation, Los Angeles, CA). 
Samples were assayed in duplicate and all samples were processed 
concurrently. Blood for these asays was collected prior to starting 
dietary treatments and on the last day of each study (d 52 in 
experiment 1 and d 46 in experiment 2). All kits gave parallel 
standard curves when added to sheep plasma. 
Statistical Analysis. Blood was collected for the determination of 
lymphocyte blastogenesis and monoclonal antibody analysis 3 times 
during each experiment. In the first experiment, animals were bled 
during wk 5, 6 and 7. In experiment 2, animals were bled during 
wk 2, 5 and 6. A mean and SEM was determined for each parameter for 
each group from these 3 blood collections. An analysis of variance 
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procedure was performed to determine the level of significance of any 
differences between groups. Duncan's multiple range test (Steel and 
Torrie, 1960) was used to determine the differences between dietary 




Average daily gain and feed consumption are shown in Table 3. In 
experiment 1 animals consumed approximately 1.34 + 0.05 kg/d and 
gained approximately 0.61 + 0.10 kg/d and in experiment 2 animals ate 
1.37 ± 0.07 kg/d and gained 0.22 + 0.04 kg/d. No significant 
differences were seen among dietary treatments. 
Serum hormone concentrations for both experiments are shown in Table 
4. No significant differences were seen in glucagon, insulin or 
Cortisol serum concentrations in either experiment; however, feeding KIC 
did tend to increase serum insulin concentrations. 
The lymphocyte blastogenic response to mitogens is summarized in 
Table 5. Feeding KIC resulted in significantly increased blastogenic 
response to PHA and PWM (KIC vs control; F < 0.05). KIC-fed animals had 
significantly higher ConÂ stimulated blastogenesls when compared to Leu-
fed animals (P < 0.05) and ConA stimulation tended to be higher when 
KIC-fed animals were compared to controls. Feeding Leu significantly 
decreased blastogenic responses to all 3 mitogens when compared to 
KIC-fed animals (F < 0.05) and tended to decrease lymphocyte 
blastogenesls when compared to controls. No changes were seen in 
background (unstimulated) blastogenesls. 
Table 6 summarizes the effects of feeding Leu or KIC on T-cell 
subset in sheep. KIC fed animals had a significantly greater percentage 
of T4 cells when compared to control and Leu fed animals (P < 0.05). 
Leu-fed animals had a signifcantly lower percentage of T19 cells when 
compared to KIC-fed animals (F < 0.05) and this number also tended to be 
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lower than the control animals. The percent of T1 cells from experiment 
2 are also shown here. No significant differences were seen in the 
percentage of Tl cells. The percentages of T4, T8 and T19 cells were 
subtracted from the percent of Tl cells resulting in a T-null (T-
unknown) subset. KIC fed animals had a significantly lower percentage 
of T-null cells when compared to the other dietary treatments (P < 
0.05). 
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Table 3. Average dally gain and feed consumption of sheep fed control, 
KIC or LEU diets (n-15) 
Average daily gain Feed consumed/day 
(kg) (kg) 
Diet 
Experiment 1 Experiment 2 Experiment 1 Experiment 2 
Control 0.577 0.220 1.41 1.35 
KIC 0,623 0.210 1.35 1.38 
Leu 0.632 0.220 1.36 1.39 
SEM^  0.10 0.04 0.05 0.07 
 ^ Pooled standard error of the mean from ANOVA 
Table 4. Mean serum hormone concentrations of sheep fed control, 
KIC or LEU diets (n-15) 
Diet Cortisol Insulin Glucagon 
(ug/dl) (uU/ml) (pg/ml) 
Control 2.7 26.1 75.8 
KIC 2.6 32.6 66.6 
Leu 2.2 26.3 65.9 
SEM^  .39 3.6 6.9 
 ^ Pooled standard error of the mean from ANOVA 
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Table 5. The effects of oral supplementation of Leu or KIC on 
lymphocyte blastogenesls In sheep ^  
Mitogen 
Diet None^  PHA^  ConA^  PWM^  
Control 700^ '* 18900^  17960*^  17320^  
KIC 776* 24870* 24130* 29780* 
LEU 730* 16160^  11840^  14520^  
SEM^  92 1975 2461 2504 
Means are of 3 repeated measures (n-15). 
2 Expressed as counts per mln per 200,000 lymphocytes 
3 Pooled standard error of the mean from ANOVA 
Means within a column not sharing a common superscript letter are 
significantly different at P < 0.05 
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Table 6. The effects of oral supplementation of LEU or KIC on T 
cell subsets In sheep 
Subset 
Diet Tl^  T4^  T8^  TI9I T-null^  
Control 56.5^ '* 18.6* 9.5* 17.9* 12.6* 
KIC 52.2* 21.3b 10.5* 18.2* 6.4b 
LEU 55.0* 18.1* 10.8* 14.9b 11.5* 
SEM^  3.1 1.0 .59 1.3 2.2 
 ^ Means are of 3 repeated measures (n-15) in both experiments 
1 and 2 
2 Mean of three repeated measures (n-8) in experiment 2 only 
3 Pooled standard error of the mean from ANOVA 
Means not sharing a common superscript letter are significantly 
different at P < 0.05 
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DISCUSSION 
No significant effects were seen on average dally gain and feed 
conversion In the present studies. In previous experiments in which KIC 
was fed at 1% of the diet to lambs, an 11% increase in gain and an 
8% increase in feed efficiency was seen (Flakoll et al., 1986). In 
other feeding trials in which steers were fed 1% KIC resulted in a 14% 
Increase in daily gain and an 8% increase in feed efficiency 
(Flakoll et al., 1987). In the present study sheep were fed a diet 
containing approximately 10% crude protein, while in earlier studies 
animals consumed diets containing 17-18% protein. These two levels of 
protein intake may be responsible for the differences in average dally 
gain and feed conversion. 
In the previous steer and sheep studies, KIC feeding decreased serum 
Cortisol concentrations. In the present studies, no changes were seen 
in serum Cortisol concentrations but only one sample was collected. 
Repeated measures of Cortisol concentrations may have led to significant 
results since the time and method of blood collection and the activity 
and metabolic state of the animal will Influence Cortisol 
concentrations. Similarly no significant changes were seen in glucagon 
and Insulin concentrations, although KIC feeding tended to Increase 
serum insulin concentrations (P < 0.10). Again, repeated measures may 
have been more suitable in evaluating hormonal changes. 
As reported in previous experiments (Kuhlman et al., 1988) mitogen 
stimulated lymphocyte blastogenesls was Increased with KIC 
supplementation. FHA and ConA are known to stimulate T-cell division, 
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while PWM stimulates both T- and B-cell mitosis in humans (Oppenheim and 
Schecter, 1980). If sheep respond to mitogens as do humans and feeding 
KIC increases the percentage of circulating T4 cells, it is consistent 
that lymphocyte blastogenesis is also increased with KIC feeding. In 
contrast to initial studies, PWM stimulated blastogenesis was also 
enhanced by KIC feeding suggesting that KIC may also stimulate B cell 
activity. This is probably the case since it was shown that in previous 
studies, KIC enhanced antibody responses to porcine red blood cells 
(Kuhlman et al., 1988). 
In sheep, peripheral T-cells are divided into three groups. The 
T4, T8 and T19 molecules mark subsets of sheep lymphocytes comprising 
15-25%, 8-12% and 20-50% of peripheral blood lymphocytes respectively 
(Mackay et al., 1989). The T4 subset represents T-helper cells which 
recognize antigen in association with major histocompatibility complex 
(MHC) class II molecules and the T8 subset represent T-cytotoxic/suppressor 
cells that recognize antigen in association with MHC class I molecules. 
Both these T-cell subsets have been identified to use the afi form of the 
T-cell receptor. While the function of the T19 subset is currently 
unknown, the T19 monoclonal antibody marks a specific subset of T-cells 
which use the fS form of the T-cell receptor (Mackay et al., 1989). 
In these experiments, the T-cell subsets defined by T4, T8 and T19 
did not comprise the entire T-cell population, as there was often a 
small population of cells which were identified when Tl was used, but 
was not when the sum of T4, T8 and T19 was considered. Â T-null subset 
was therefore reported. 
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The results of these experiments suggest that dietary Leu and KIC 
alter the percentage of circulating T-lymphocyte subsets and these 
alterations may be responsible for the changes previously observed in 
lymphocyte blastogenesis and antibody responses. In the case of KIC, 
the percentage of T4 cells was increased approximately 15% which could 
be responsible for the increase in blastogenesis and antibody 
production. Additionally, the T-null subset was significantly decreased 
which could also relate to the observed effects of KIC on immune 
function. In the case of Leu, the only observed change was a 17% 
decrease in T19 cells for which a function has not yet been described. 
The fact that these two compounds affect two distinct T-lymphocyte 
subsets in opposing ways, may partially explain the mechanism of the 
opposite effects that Leu and KIC exert on immune function. 
In conclusion, these data suggest that the dietary supplementation 
of KIC may increase blastogenesis by increasing the number of T-helper 
lymphocytes, whereas Leu decreases blastogenesis by decreasing the 
number of T19 lymphocytes in the peripheral blood circulation. 
48 
LITERATURE CITED 
Abumrad, N. N., K. L. Wise, P. E. Williams, N. A. Abumrad and W. W. 
Lacy. 1982. Disposal of a-ketoisocaproate: roles of liver, gut and 
kidneys. Am. J. Physiol. 243:E123-E130. 
Bergman, E. N. 1986. Splanchnic and peripheral uptake of amino 
acids in relation to the gut. Fed. Proc. 45:2277-2282. 
Burroughs, W., Nelson, D. K. and Mertens, D. R. 1975. Evaluation of 
protein nutrition by metabolizable protein and urea fermentation. J. 
Dairy Sci. 58:611-619. 
Busboom, J. R., R. A. Merkel and W. G. Bergen. 1984. Comparison of 
leucine aminotransferase and alpha-ketolsocaproate dehydrogenase 
activities in growing sheep, cattle, swine and rats. J. Anim. Sci. 
59(Suppl. 1):412 (Abstr.). 
Flakoll, P. J., P. Ostaszewski and S. L. Nlssen. 1986. Evaluation of 
lamb performance in response to intravenous and intraperitoneal 
administration of 2-ketolsocaproate. J. Anim. Sci. 63(Suppl. 1):452 
(Abstr). 
Flakoll, P. J., M. J. VandeHaar, G. Kuhlman, J. A. Roth and S. Nlssen. 
1987. Evaluation of steer growth. Immune function, and carcass 
composition in response to oral administration of ruminally protected 2-
ketoisocaproate. J. Anim. Sci. 65(Suppl. 1):476 (Abstr.). 
Kuhlman, G., Roth, J. A., Flakoll, P. J., VanderHaar, M. J. and Nlssen, 
S. 1988. Effects of dietary leucine, a-ketoisocaproate and Isovalerate 
on antibody production and lymphocyte blastogenesls in growing lambs. 
J. Nutr. 118:1564-1569. 
Leclercq-Heyer,V., J. Marchand, R. Leclercq and W. J. Malaisse. 
1979. Interactions of a-ketoisocaproate, glucose and arglnine in the 
secretion of glucagon and Insulin from the perfused rat pancreas. 
Diabetologia 15:121-126. 
Mackay, C. R., M.-Françoise Beya and P. Matzlnger. 1989. yS T cells 
express a unique surface molecule which appears late during thymic 
development. Eur. J. Immunol., in press. 
Mackay, G. R., Maddox, J. F. and Brandon, M. R. 1986. Three distinct 
subpopulations of sheep T-lymphocytes. Eur. J. Immunol. 16:19-25. 
Mackay, C. R., Maddox, J. F. Gogolin-Evens, K. J. and Brandon, M. R. 
1985. Characterization of two sheep lymphocyte differentiation 
antigens, SBU-Tl and SBU-T6. Immunology 55:729-737. 
49 
Maddox, J. F., Mackay, C. R. and Brandon, M. R. 1985. Surface 
antigens, SBU-T4 and SBU-T8, of sheep T lymphocyte subsets defined by 
monoclonal antibodies. Immunology 55:739-748. 
Nissen, S. and P. Ostaszewski. 1985. Effects of supplemental 
dietary energy on leucine metabolism in sheep. Br. J. Nutr. 54:705-
712. 
Oppenheim, J. J. and B. Schecter. 1980. Lymphocyte transformation, 
pp. 233-245. In (Rose, N. R. and Friedman, H., eds.). Manual of Clinical 
Immunology American Society for Microbiology, Washington, D.C. 
Parrillo, J. E. and A. S. Fauci. 1979. Mechanisms of glucocorticoid 
action on imune process. Am. Rev. Pharmacol. Toxicol. 19:179-201. 
Pell, J. M., E. M. Caldarone and E. N. Bergman. 1986. Leucine and 
-ketoisocaproate metabolism and interconversion in fed and fasted 
sheep. Metabolism 35:1005-1016. 
Roth, J. A., Kaeberle, M. L. and Hsu, W. H. 1982. Effects of ACTH 
administration on bovine polymorphonuclear leukocyte function and 
lymphocyte blastogenesis. Am. J. Vet Res. 43:412-416. 
Steel, R. G. D. and Torrie, J. H. 1960. Principles and Procedures of 
Statistics. McGraw-Hill, New York. 
50 
SECTION II. THE EFFECTS OF LEUCINE AND a-KETOISOCAPROATE ON ACTH-
INDUCED IMMUNOSUPPRESSION IN SHEEP 
51 
The Effects of Leucine and a-Ketolsocaproate on ACTH-Induced 
Immunosuppression In Sheep^  
2 3 2 4 Gall Kuhlman , James A. Roth and Steven Nlssen ' 
 ^Journal Paper No. J- of the Iowa Agriculture and Home 
Economics Experiment Station, Ames; Project . This was supported 
in part by NIH Grant No. AM32540 and a grant funded by the Iowa Sheep 
Producers Assn. 
2 3 Department of Animal Science and Department of Veterinary 
Microbiology and Preventive Medicine, Iowa State University, Ames, lA 
50011 
A^ppreciation Is expressed to R. Wllhelm, B. Mitchell, R. Berryman 
and the farm crew at the ruminant nutrition research farm for diet 




The effects of oral administration of leucine (Leu) and its first 
catabolic product, a-ketoisocaproate (KIC), on adrenocorticotrophic 
hormone (ACTH) induced immunosuppression in sheep were determined. 
Immune status was monitored by lymphocyte blastogenic responsiveness to 
mitogens and enumeration of the percentage of T-cells and T-cell subsets 
in the peripheral blood by using monoclonal antibodies and a flow 
cytometer. Twenty-four mixed-breed ewe lambs were fed diets 
supplemented with 0.10% ruminally protected; limestone (control), KIC or 
Leu for 60 d. Animals were then injected with either saline or ACTH 
(100 lU) twice daily for 3 consecutive d, at which time they remained on 
appropriate dietary treatments. Serum Cortisol, insulin and glucagon 
concentrations were determined. ACTH injections increased both serum 
Cortisol and insulin concentrations. No effects were seen in serum 
glucagon concentrations. Mitogen stimulated lymphocyte blastogenesls 
was determined by adding phytohemmagglutlnln F (FHA), concanavalln A 
(ConA) or pokeweed mitogen (FWM) to isolated lymphocytes and measuring 
H-thymidine incorporation. ACTH administration significantly 
suppressed mitogen stimulated lymphocyte blastogenesls by approximately 
50% regardless of the mitogen used (F < 0.05). KIC-fed animals had 
greater FHA and ConA stimulated blastogenic responses when compared to 
Leu-fed or control animals given corresponding injections (F < 0.05). 
ACTH Injections tended to decrease the percentage of total circulating 
T- lymphocytes when compared to saline Injected animals. Leu-fed 
animals injected with ACTH had a significantly lower percentage of T-
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cells when compared to Leu-fed animals injected with saline (P < 0.02). 
KIC-fed animals tended to have an increased percentage of stained T4 
cells when compared to control and Leu-fed animals (P < 0.07). These 
data indicate that ACTH decreased in vitro lymphocyte blastogenesis and 
altered the subset ratios of circulating peripheral lymphocytes in 
sheep. These changes were partially reversed by feeding KIC, although 
KIC could not completely prevent the suppressive effects of ACTH on T-
lymphocyte function. 
(Keywords: Sheep, Leucine, a-Ketoisocaproate, Immunosuppression, 
T cell subsets, Adrenocorticotophic Hormone.) 
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INTRODUCTION 
Stress is believed to be associated with immunosuppression and 
therefore can contribute to disease development in a number of domestic 
food animals such as cattle (Hoerlin and Marsh, 1957) and pigs (Westly 
and Kelley, 1984). An important response of the body to stress is the 
secretion of pituitary-derived adrenocorticotrophic hormone (ACTH) which 
stimulates the adrenal gland to release glucocorticoids (Stephens, 
1980). It is believed that this increase in plasma corticosteroid 
concentration is an Important factor in stress-induced immunosuppression, 
in that glucocorticoids are known to impair lymphocyte and neutrophil 
functions (Roth et al., 1982; Westly and Kelley, 1984). Therefore, to 
reduce immunosuppression caused by stress, either glucocorticoid 
secretion could be prevented or the action of glucocorticoids on these 
cell types could be prevented. 
Dietary leucine (Leu) supplementation has been shown to suppress 
various indices of immune function (Chevalier and Aschkenasy, 1977; 
Tinker and Gous, 1986; Kuhlman et al., 1988), its first catabolic 
product, Q-ketoisocaproate (KIC) has been shown to exert an enhancing 
effect on T-cell dependent antibody production and lymphocyte 
blastogenesis when orally administered to sheep (Nissen et al., 1986; 
Kuhlman et al., 1988). KIC has also been shown to stimulate lymphocyte 
blastogenesis when fed to growing steers for eight wk (Flakoll et al., 
1987). However, the effects of KIC on lymphocyte function in 
immunosuppressed animals is not known. 
The purpose of the present study was to determine if ACTH 
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administration would alter T-lymphocyte number and function and to 
determine if the a-keto acid of leucine (a-ketoisocaproate) could 
overcome any immunosuppressive effects caused by ACTH administration. 
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MATERIALS AND METHODS 
Animals. Diets and Experimental Design. Twenty four mixed-breed ewe 
lambs, approximately 5 mo of age, were randomly assigned to one of three 
dietary treatments; Leu (n-8), KIC (n-8) or limestone (control; n-8). 
Dietary treatments were supplemented to the basal diet (Table 1) In the 
form of zeln coated pellets. The composition and method of preparation 
of these pellets have been previously described (Kuhlman et al., 1988). 
Lambs were fed their respective pellets at a rate of approximately 3 
g/d, which corresponds to approximately 5 mmol of Leu or KIC per kg of 
2 diet. Lambs were housed individually in fiberglass pens (1.15 m ) in 
which they were allowed free access to water and food. 
Animals were fed their appropriate diets for approximately sixty 
d. At this time each group of eight lambs was randomly divided Into 
two subgroups of four lambs, a saline-injected or an ACTH-injected 
subgroup. The ACTH-injected subgroup was given 100 lU of ACTH (Sigma 
Chemical Co., St. Louis, MO.), intramuscularly, every 12 h for 
3 consecutive d. The ACTH (1000 lU) was suspended in 2 ml O.IM 
hydrochloric acid (HCl) and 10 ml saline/0.5% bovine serum albumin 
(BSA). The saline injected ewes were given injections of the 
HCl/saline/BSA solution (without ACTH) at corresponding times. Blood 
was collected prior to ACTH treatment and then daily, in the morning 
before Injections, for 3 d. 
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Table 1. Composition of basal diet fed to all sheep* 
Ingredient kg Dry Matter 
Ground corn 52.5 
Dehydrated alfalfa 31.2 
Expeller soybean meal^  10.2 
Molasses 4.4 
Trace mineral & vitamin premlx^  .57 
Salt .56 
Limestone .57 
* Formulated to contain 1.7 Meal net energy/kg for maintenance, 
1.2 Meal net energy/kg for gain, 16% crude protein and 88.5% dry 
matter. 
 ^Purchased from West Central Cooperative, Ralston, lA. 
Purchased from Feed Specialties Co., Des Moines, lÀ. Contains 1.64% 
Mg, 4949 mg Mn/kg, 371 mg Zn/kg, 2600 mg Fe/kg, 0.05 mg Cu/kg, 
47.4 mg Co/kg, 128 mg I/kg, 25 mg Se/kg, 3.25% S, 772727 USP 
Units vitamin A/kg, 102273 USP Units vitamin D3/kg, and 773 lU 
vitamin E/kg. 
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Lymphocyte Preparation. Blood (50 ml) was collected yla jugular 
venepuncture aseptically into 10 ml acid-citrate-dextrose anticoagulant 
(44 g trisodium citrate, 16 g citric acid and 50 g dextrose per 1 of 
triple distilled water). Blood was centrifuged and 1 vol of buffy coat 
was diluted with one half vol of plasma and was added to 2 vol of 
Sepracell-MN (Sepratech Corporation, Oklahoma City, OK). After further 
centrifugation at 1500 x g for 25 min, the mononuclear layer was removed 
and washed twice with Hanks' balanced salt solution (HBSS; Gibco, Grand 
Island, NY) by centrifuging at 150 x g for 15 min. The remaining white 
blood cells were resuspended in HBSS and the total number of white blood 
cells were determined using an automated cell counter (Coulter 
Electronics, Hialeah, FL). The concentration of the cells was adjusted 
to 1 X 10^  cells/ml with HBSS. 
Lymphocyte Blastoeenesls Determinations. Blastogenesis assays were 
performed on isolated lymphocytes by using a 3-d culture procedure as 
described previously (Roth et al., 1982). Briefly, isolated lymphocytes 
were cultured in microtiter plates with 2 x 10^  cells in 0.15 ml of 
culture medium/well. Culture medium consisted of RPMI medium-1640 
(Gibco, Grand Island, NY) containing 15% heat-inactivated fetal bovine 
serum and 1% antibiotic-antimycotic solution (Grand Island Biological, 
Grand Island, NY). Unstimulated and mitogen stimulated cultures were 
assayed in triplicate. Mitogens used were phytohemagglutinin-P (PHA), 
concanavalin A (ConA) and pokeweed mitogen (FWH). PHA was purchased 
from Difco Laboratories, Detroit, MI; ConA from Miles Laboratories, 
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Elkhart, IN; and FWM from Grand Island Biological, Grand Island, NY. 
Microtiter plates were Incubated at 37° G In a humidified 5% COg 
3 
atmosphere. After 48 h, 0.25 uCi of H-thymidine (New England Nuclear, 
Boston, MA) was added to each well. Eighteen h later, the cultures were 
harvested onto glass-fiber filters with an automated sample harvester 
(Flow Laboratories, Rockvllle, MO), filters were placed in 10 ml 
CytoScint scintillation solution (ICN Biomedicals, Irvine, CA) and 
radioactivity was counted in a liquid scintillation counter. 
Antibodies. A panel of monoclonal antibodies directed against sheep 
T-lymphocyte surface determinants (Table 2) was used. Monoclonal 
antibodies, in the form of cell-free culture supernatants were obtained 
from Dr. M.R. Brandon, University of Melbourne, Parkville, Victoria, 
Australia. Additional properties of the antigens recognized by the 
monoclonal antibodies have been reviewed elsewhere (Mackay et al., 1985; 
Maddox et al., 1985; Mackay et al., 1986). A fluoresceinisothiocyanate-
conjugated rabbit F(ab')2 anti-mouse immunoglobulin (FITC-RAM) was 
purchased from DAKO Corporation, Carpinteria, CA. 
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Table 2. Properties of monoclonal antibodies used 
Antibody Molecular wt of Human/murine % stained peripheral 
designation target antigen analogue lymphocytes 
SBU-Tl 67,000 Tl/Lyl 60-80 
SBU-T4 56,000 T4/L3T4 20-50 
SBU-T8 36,000 T8/Ly2 10-20 
SBU-T19 215,000 ? 15 
Immunofluorescent staining. Sheep lymphocytes (10*) in 50 ul 
phosphate-buffered saline, 0.1% sodium azide (PBS/Az), 0.5% BSA were 
incubated for 30 mln at 4° C with 50 ul monoclonal antibody culture 
supernatant. Additionally, cells were incubated with monoclonal 
antibody culture supernatant only and with FITG-RAM only so that any 
nonspecific fluorescent staining could be determined. Nonspecific 
labelling averaged approximately 1-2% and was therefore not considered 
an important variable in this study. The cells were washed twice with 
PBS/Az by centrifuglng at 150 x g for 15 min and incubated with 40 ul of 
FITC-EIAM for 30 min at 4° C. Cells were washed 3 times with PBS/Az, 
resuspended in 200 ul 1% formalin and stored overnight at 4° C until 
analyzed. 
Flow Cytometric Analysis. Fluorescent stained cells were detected 
using an EPICS 752 flow cytometer (Coulter Electronics, Hialeah, FL). 
Light passing to the fluorescence detector was split using a 488 nm 
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dichroic filter. FITC fluorescence was collected through a 515 long 
pass filter and the presence or absence of a range of cell surface 
markers was determined. Only cells containing the lymphocyte 
populations indicated by the forward angle light and 90° light scatter 
histograms were analyzed for fluorescence using the EASY88 computer 
system with Intgra software (Coulter Electronics, Hialeah, FL). A 
minimum of ten thousand events were collected per sample. All data are 
presented as percent positive cells or ratios of these percents. 
Determination of Serum Cortisol Concentrations. Serum Cortisol 
concentrations were determined by a coated tube single antibody 
radioimmunoassay using a commercial kit (Diagnostic Products 
Corporation, Los Angeles, CA). Samples were assayed in duplicate and 
all samples were processed concurrently. The Cortisol antiserum used in 
the radioimmunoassay was specific for Cortisol with an extremely low 
cross-reactivity to other naturally occurring steroids. 
A subsequent experiment was conducted to verify the time course of 
Cortisol appearance after ACTH injection. Sheep were injected with 
either ACTH (n-3) or saline (n-2) every 12 h for 3 consecutive d. 
Blood samples were collected once/d for the 3 d period, serum was 
removed and cotisol concentrations were determined. 
Serum insulin and glucagon concentrations were also determined. 
Insulin concentrations were measured using a coated tube single antibody 
radioimmunoassay kit (Diagnostic Products Corporation, Los Angeles, CA). 
The insulin antiserum was highly specific for insulin, with particularly 
62 
low crossreactlvlty to compounds other than Insulin and prolnsulln. 
Serum glucagon was measured with a double antibody radioimmunoassay kit 
(Diagnostic Products Corporation, Los Angeles, CA). This procedure is 
highly specific for intact glucagon and glucagon fragments with no 
crossreactlvlty for related compounds. All kits gave parallel 
standard curves when added to sheep plasma. 
Statistical Analysis. Blood was collected from both groups for the 
determination of lymphocyte blastogenesls and for monoclonal antibody 
analysis immediately before beginning the ACTH treatment. A mean was 
determined for each parameter for each group and a two-way analysis of 
variance procedure was performed to determine the level of significance 
of any differences among groups before ACTH administration. Pooled S EM 
were taken from ANOVA. These blood samples were collected to assure 
that no significant differences were seen between injection subgroups 
within the same dietary treatment. Blood was collected three times 
(once/d) during the ACTH administration treatment. A mean was 
determined for each parameter for each group from these three blood 
collections. A two-way ANOVA procedure was performed to determine the 
level of significance of any differences between the two groups during 
ACTH treatment. Pooled SEM were taken from ANOVA. Conservative degrees 
of freedom were used in the F tests. The Interactions between dietary 




No significant differences were seen between animals In serum 
Cortisol concentrations prior to injections within dietary treatments. 
The data in Table 3 indicate that serum Cortisol concentrations were 
elevated within 2 h after ÂCTH administration and returned to basal 
values within 10-12 h. In the present study, serum hormone 
concentrations were determined on blood samples collected once/d for 3 
consecutive d. Each sample was therefore collected 12 h after ÂCTH 
administration. Although no significant differences were observed in 
serum Cortisol concentrations at 12 h after ÂCTH administration, ÂCTH-
injected animals tended to have higher serum Cortisol concentrations 
regardless of the dietary regime (Table 4). Serum Cortisol 
concentrations of the ACTH-treated group averaged 2.3 ug/dl and averaged 
1.6 ug/dl for the saline treated groups. When compared to control 
animals, the KIC-fed animals tended to have lower serum Cortisol 
concentrations regardless of the type of Injection. 
ÂCTH-injected animals fed control diets had Increased serum insulin 
concentrations when compared to all other dietary treatments without 
ACTH (P < 0.09). Although not significant, ACTH-injected groups had 
increased serum insulin concentrations when compared to saline-injected 
groups. No significant differences were seen in serum glucagon 
concentrations (Table 4). 
Before the administration of the injections, there was no 
significant differences observed between injection groups in any of the 
parameters measured. The results obtained from the lymphocyte 
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blastogenesls assays are shown In Table 5. Each value represents the 
average of 3 collections (1/d). Mitogen-stimulated blastogenesls 
responses generally tended to be Increased when KIC was fed and 
decreased when Leu was fed. 
ACTH administration significantly suppressed lymphocyte 
blastogenesls by up to 52%, 50% and 63%, respectively, when FHÂ, ConA or 
FUM were used (P < 0.05) when compared to saline injected groups, KIC-
fed animals not injected with ACTH had significantly increased 
blastogenesls responses when all 3 mitogens were used. KIC-fed animals 
injected with ACTH had a greater blastogenesls response when compared to 
Leu-fed or control animals given ACTH. No significant changes were 
observed in unstimulated lymphocyte blastogenesls. 
In the preinjection analysis, no significant differences were seen 
in T-cell subsets between injection groups within the same dietary 
treatment. Table 6 shows the results obtained from the flow cytometric 
analysis of T-lymphocyte subsets. The total percentage of each subset 
was used for statistical analysis. KIC-fed animals tended to have 
increased T4 cell percentages when compared to animals fed control or 
Leu supplemented diets. Also, ACTH treatment of Leu-fed animals 
significantly lowered the percentage of T-lymphocytes (P < 0.005). This 
decrease in total T-cell percentage was due to a decrease in T19 
lymphocytes (P < 0.02). 
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Table 3. The effects of ACTH administration on serum Cortisol 
concentrations in sheep 
Mean ± SEM 
Hours after injection Saline (ug/dl) ACTH (ug/dl) 
(n-2) (n-3) 
0 1.09 ± 0.23 1.22 ± 0.57 
2 0.86 + 0.24 15.60 ± 2.50 
4 0.83 ± 0.41 15.06 ± 1.98 
6 0.69 + 0.22 8.84 ± 2.10 
8 0.53 ± 0.20 5.20 ± 1.80 
10 0.45 ± 0.15 2.76 ± 1.20 
12 0.76 ± 0.33 1.69 + 0.72 
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Table 4. The effects of ACTH administration^  on mean serum 
hormone concentrations In sheep (n«4) fed control, KIC or Leu 
diets for 60 days 
Diet Cortisol Insulin Glucagon 
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 ^ Average of 3 days 
 ^ Pooled standard error of the mean from ANOVA 
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Table 5. The effects of ACTH administration^  on lymphocyte blastogenesls 
in sheep (n-4) fed control, KIC or Leu diets for 60 days 
Mitpgen = 
Counts/minute/2xlO cells 
Diet None 2H6 GonA PWM 
Control 
Saline 471 19700 18600 23400 
ACTH 678 11200^  10300^  14300^  
KIC 
Saline 430 33200* 38800* 41000* 
ACTH 497 16000^  19400^  23300^  
Leu 
Saline 746 14300 18100 28300 
ACTH 750 9700^  9790^  10400^  
SEM^  158 3600 5300 6700 
Probability values for main effects and interactions 
Diet .22 .008 .016 .012 
Injection .48 .003 .013 .015 
Diet* 
Injection .81 .23 .50 .77 
 ^ Average of 3 days 
 ^ Pooled standard error of the mean from ANOVA 
F < 0.05, as compared to all other diet and ACTH injection treatments 
P < 0.05, as compared to the same diet without ACTH 
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Table 6. The effects of ACTH administration^ on T-cell 
subsets in sheep fed control, KIC or Leu diets for 60 days 
Subset 
% stained peripheral lymphocytes 
Diet Ï1 ïâ 18 T19 
Control 
Saline 56.4 15.4 10.3 20.7 
ACTH 46.7 14.4 11.4 19.1 
KIC 
Saline 57.6 21.3 11.1 23.1 
ACTH 49.3 18.8 11.4 19.6 
Leu 
Saline 63.7 17.6 12.7 25.8 
ACTH 47.4* 15.5 13.9 15.3* 
SEM^  4.4 2.1 1.1 2.6 
Probability values for main effects and interactions 
Diet .66 .07 .09 .86 
Injection .005 .29 .38 .02 
Diet* 
Injection .63 .93 .91 .22 
® Average of 3 days 
 ^ Pooled standard error of the mean from ANOVA 
* 
P < 0.05, as compared to same diet without ACTH 
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DISCUSSION 
The present study suggests that the treatment regime of 100 lU of 
ACTH injected intramuscularly every 12 h stimulates the secretion of 
Cortisol. Blood was collected 12 h after ACTH injections so that serum 
Cortisol, insulin and glucagon concentrations could be determined. 
These values may not reflect the acute effects of ACTH administration 
due to the time of blood collection. As shown in the subsequent 
experiment, Cortisol concentrations almost returned to baseline values 
by 12 h after injection. Cortisol values did, however, tend to be 
higher in the ACTH injected groups than those of the saline injected 
groups. Similarly, blood insulin increased with ACTH which has been 
shown to occur in rats (Sussman and Vaughan, 1967) and mice (Genuth and 
Lebovitz, 1965). The mechanism of the marked suppression in mitogen-
stimulated blastogenesis seen in this study with the administration of 
ACTH is currently unknown. It may be due to a direct effect of ACTH on 
the lymphocytes to inhibit mitosis, to a corticosteroid-induced 
Inhibition of T-cell growth factor production by mononuclear cells or to 
a redistribution of a proportion of the lymphocytes out of circulation 
and into an extravascular lymphocyte compartment. The latter possibility 
is supported in the present study since two distinct peripheral blood T-
cell subsets, T4 and T19, tended to decrease after ACTH administration. 
T4 cells represent a subset of T-helper cells bearing the afi T-cell 
receptor (Maddox, 1985) and T19 cells represent a subset of T cells 
bearing the fS T-cell receptor (Mackay et al., 1989). 
In man, the administration of glucocorticoids causes the 
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recirculating lymphocytes to leave the intravascular space and to enter 
the tissues, but nonrecirculating lymphocytes are not affected (Parrillo 
and Fauci, 1979). This selective depletion of T-lymphocytes from the 
peripheral blood may be responsible for the decreased responsiveness of 
peripheral blood lymphocytes in man to T-cell mitogens. This may also 
be the case in sheep. It has been shown that in sheep a 16-22% 
reduction of the output of lymphocytes into the efferent lymph results 
from giving an intravenous infusion or a bolus injection of a Cortisol 
analog, methylprednisolone (Zukoski and Montgomery, 1983). 
These data support the argument that in sheep, as in man, AGTH 
induces a selective sequestering of T-lymphocytes in the lymphoid 
tissues and this sequestering may be responsible for the decrease seen 
in lymphocyte blastogenesis following ACTH administration. These data 
also suggest that KIC may partially decrease the sequestering of T4 and 
T19 peripheral blood lymphocytes seen in control and Leu-fed animals 
given ACTH in this study. KIC-fed animals tended to have larger 
percentages of circulating T4 cells after ACTH injection (P < 0.07). 
KIC feeding suceeded in partially overcoming the depression in mitogen-
stimulated lymphocyte blastogenesis seen after ACTH administration. 
In a study in which insulin was added to the culture media, insulin 
enabled T-cell proliferation in a murine one-way mixed lymphocyte 
reaction (Snow, 1985). Therefore, insulin may be involved in the 
regulation of lymphocyte blastogenesis. However, in the present study, 
Cortisol may have interferred with insulin action and thus the cultured 
lymphocytes may have been resistant to the action of insulin. In other 
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studies, the administration of excess ACTH to rats resulted In a state 
of Insulin resistance (Kahn et al., 1978). Thus, the suppression of 
blastogenesls by ACTH may have been the result of a direct action of 
Cortisol on lymphocyte function and may have Interferred with the 
Indirect action of insulin on lymphocyte function. 
In conclusion, ACTH injections partially stimulate the endocrine 
pattern of acute stress and lymphocyte blastogenesls which may be due to 
a selective depletion of T4 and T19 peripheral lymphocytes in sheep. 
Also, KIC was partially effective In preventing or reversing the 
suppressive effects of ACTH on T-lymphocyte function when fed at a rate 
of 5 mmol/kg total diet. 
72 
LITERATURE CITED 
Chevalier, Ph. and A. Aschkenasy. 1977. Hematological and 
Immunological effects of dietary leucine In the young rat. Am J. 
Clin. Nutr. 30:1645-1654. 
Flakoll, P. J., H. J. VanderHaar, G. Kuhlman, J. A. Roth and S. Nissen. 
1987. Evaluation of steer growth, Immune function and carcass 
composition in response to oral administration of ruminally 
protected 2-ketoisocaproate. J. Anim. Sci. 65(Suppl.):476 (Abstr.), 
Genuth, S. and H. E. Lebovltz. 1965. Stimulation of insulin release 
by corticotropin. Endocrinology 76:1093-1099. 
Hoerlln, A. B. and C. L. Marsh. 1957. Studies on the eplzootiology of 
shipping fever in calves. J. Am. Vet. Med. Assoc. 131:123-127. 
Kahn, C. R., I. D. Goldfine, D. M. Neville, and P. DeMeyts. 1978. 
Alterations in insulin binding induced by changes in vivo in the 
levels of glucocorticoids and growth hormone. Endocrinology 
103:1054-1066. 
Kuhlman, G., J. A. Roth, P. J. Flakoll, M. J. VanderHaar and S. Nissen. 
1988. Effects of dietary leucine, a-ketoisocaproate and 
Isovalerate on antibody production and lymphocyte blastogenesls in 
growing lambs. J. Nutr. 118:1564-1569. 
Mackay, C. R., J. F. Maddox, K. J. Gogolin-Evens and M. R. Brandon. 1985. 
Characterization of two sheep lymphocyte differentiation antigens, 
SBU-Tl and SBU-T6. Immunology 55:729-737. 
Mackay, C. R., J. F. Maddox and M. R. Brandon. 1986. Three distinct 
subpopulations of sheep T-lymphocytes. Eur. J. Immunol. 16:19-25. 
MacKay, C. R., M. F. Beya and P. Matzlnger. 1989. T cells express a 
unique surface molecule which appears late during thymic development. 
Eur. J. Immunol., in press. 
Maddox, J. F., C. R. Mackay and M. R. Brandon. 1985. Surface antigens, 
SBU-T4 and SBU-T8, of sheep T lymphocyte subsets defined by 
monoclonal antibodies. Immunology 55:739-748. 
Nissen, S., P. J. Flakoll and J. A. Roth. 1986. Enhanced lymphocyte 
blastogenesls by 2-ketoisocaproate in young lambs. Fed. Proc. 
45:240 (Abstr.). 
Parrillo, J. E. and A. S. Fauci. 1979. Mechanisms of glucocorticoid 
action on immune processes. Ann. Rev. Pharmacol. Toxicol. 19:179-
201. 
73 
Roth, J. A., H. L. Kaeberle and W. H. Hsu. 1982. Effects of ACTH 
administration on bovine polymorphonuclear leukocyte function and 
lymphocyte blastogenesls. Am. J. Vet Res. 43(3):412-416. 
Snow, E. C. 1985. Insulin and growth hormone function as minor growth 
factors which potentiate lymphocyte activation. J. Immunol. 135 
(Suppl. 2):7765-7785. 
Stephens, D. B. 1980. Stress and its measurement in domestic animals; A 
review of behavioral and physiological studies under field and 
laboratory situations. Adv. Vet. Sci. Comp. Med. 24:179-210. 
Sussman, K. E. and G. Vaughan. 1967. Insulin release after ACTH, 
glucagon, and adenosine-3'-5'-phosphate (cyclic AMP) in the perfused 
isolated rat pancreas. Diabetes 16:449-454. 
Tinker, K. J. and R. M. Gous. 1986. The effect of a dietary leucine 
excess on the immunoresponsiveness and growth of chickens. S.-Afr. 
Tydskr. Veekd. 16:187-191. 
Westly, H. J. and K. W. Kelley. 1984. Physiological concentrations of 
Cortisol suppress cell-mediated immune events in the domestic pig. 
Proc. Soc. Expt. Biol. Med. 177:156-164. 
Zukoski, C. F. and D. W. Montgomery. 1983. Alteration of sheep lymph 
node function by methylprednisolone. Transplant Proc. 15:566-572. 
74 
SECTION III. a-KETOISOCAPROATE ENHANCES OVINE LYMPHOCYTE BLASTOGENESIS 
THROUGH PRODUCTION OF ^ -HYDR0XY-/9-METHYLBUTYRATE 
75 
a-Ketolsocaproate Enhances Ovine Lymphocyte Blastogenesls Through 
Production of j9-Hydroxy-^-methyIbutyrate 
2 3 2 6 Gall Kuhlman , James A. Roth and Steven Nlssen ' 
J^ournal Paper No. J- of the Iowa Agriculture and Home 
Economics Experiment Station, Ames; Project . This was supported 
in part by NIH Grant No. AM32540 and a grant funded by the Iowa Sheep 
Producers Assn. 
2 3 Department of Animal Science and Department of Veterinary 
Microbiology and Preventive Medicine, Iowa State University, Ames, lA 
50011 
/t 
Appreciation is expressed to J. Kent for animal care and A. Dorn 
for laboratory assistance. 
76 
ABSTRACT 
Experiments were conducted to determine if the in vivo suppression 
of lymphocyte blastogenesis by leucine (Leu) and the in vivo stimulation 
of lymphocyte blastogenesis by a-ketoisocaproate (KIC) were due to 
direct effects of these compounds on blastogenesis. Peripheral blood 
lymphocytes were isolated and cultured in the presence of 1 and 10 mM 
Leu, KIC, isovalerate (IVA), hydroxy-^ -methylbutyrate (HMB), /8-
hydroxy-^ -methylglutarate (HMG), butyrate, acetate, acetone, 
acetoacetate (AcAc) and ^ -hydroxybutyrate (BOHB). Cells were then 
incubated with the mitogen phytohemagglutinin-P (PHA) and the 
3 incorporation of H-thymidine into the DNA of the dividing lymphocytes 
was measured. Leu suppressed blastogenic responses by approximately 25% 
at a concentration of 10 mM, while KIC and IVA did not alter 
blastogenesis. BOHB significantly enhanced blastogenesis by 
approximately 50% while HMB increased blastogenesis by approximately 
100% at a concentration between 1-10 mM. HMB increased responses by 
approximately 2 fold more than BOHB, although both metabolites enhanced 
responses at all concentrations used. The maximum change over the 
control in blastogenesis occurred at low doses of both HMB and BOHB. In 
conclusion, the effects of Leu in vivo can be explained by a direct 
effect of the compound, but the effects of KIC in vivo may be due to a 
hydroxy acid metabolite of the compound. 
(Keywords; Sheep, Leucine, a-Ketoisocaproate, Hydroxy-methyIbutyrate) 
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INTRODUCTION 
Previous studies indicate that the oral supplementation of leucine 
(Leu) suppressed in vitro lymphocyte blastogenesis and production of 
antibodies in sheep while the first catabolic product of Leu, a-
ketoisocaproate (KIC), enhanced ovine lymphocyte blastogenesis and 
antibody production (Kuhlman et al,, 1988). In the same study another 
metabolite of Leu, isovalerate (1VÂ), did not affect these same 
parameters. In other studies, it was determined that feeding KIC to 
lambs at 1% of the diet for 8 wk resulted in a two-fold increase in PHÂ 
stimulated lymphocyte blastogenesis (Nissen et al., 1986). In cattle, 
feeding KIC at 0.07% of the diet resulted in a significant increase in 
unstimulated and mitogen stimulated lymphocyte blastogenesis (Flakoll et 
al., 1987). Since these studies involved the feeding of these 
compounds, a direct effect of the compound Itself or an Indirect effect 
of a metabolite of the compound could be possible. 
To determine if these compounds are directly responsible for the 
observed changes in lymphocyte blastogenesis, the effects of various 
concentrations of Leu and Leu metabolites on the mitogenic stimulation 
of ovine lymphocytes were determined. The metabolites used were Leu, 
KIC, IVA, ^ -hydroxy-p-methylbutyrate (HMB), 
-^hydroxy-^ -methylglutarate (HMG), ^ -hydroxybutyrate (BOHB), butyrate, 
acetate, acetone and acetoacetate (AcAc). Dose response curves were 
therefore constructed for HMB and BOHB because they significantly 
stimulated lymphocyte blastogenesis when Incubated with the mitogen 
stimulated lymphocytes. To assure that these enhanced effects were due 
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specific compounds and not to all hydroxy acids, a-hydroxybutyrate 
(ÂOHB), 7-hydroxybutyrate (GOHB), a-hydroxylsovalerate (AOHI) and 
cltramallc acid (Clt) were also included as metabolites in the 
lymphocyte blastogenesis assays. 
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MATERIALS AND METHODS 
Animals. Mature mixed-breed ram and ewe sheep were used. All 
animals were fed a corn-soybean meal based diet with adequate protein. 
Water was provided at all times. 
Lymphocyte Preparation. Blood (50 ml) was aseptically collected via 
jugular venapuncture into 10 ml acid-citrate-dextrose anticoagulant (44 
g trisodium citrate, 16 g citric acid and 50 g dextrose per 1 of triple 
distilled water). Blood was centrifuged, the buffy coat was removed and 
1 vol of buffy coat was diluted with one half vol of plasma and was 
added to 2 vol of Sepracell-MN (Sepratech Corporation, Oklahoma City, 
OK). After further centrifugation at 1500 x g for 25 min, the 
mononuclear layer was removed and washed twice with Hanks' balanced salt 
solution (HBSS; Gibco, Grand Island, NY) by centrifuging at 150 x g for 
15 min. The remaining white blood cells were resuspended in HBSS and 
the total number of white blood cells were determined using an automated 
cell counter (Coulter Electronics, Hialeah, PL). Cells were adjusted to 
a concentration of 1 x 10^  cells/ml with RFMI media-1640 (Gibco, Grand 
Island, NY). 
Lymphocyte Blastoeenesis Determinations. Blastogenesis assays were 
performed on isolated cells by using a 3-d culture procedure as 
described previously (Roth et al., 1982). Briefly, isolated lymphocytes 
were cultured in microtiter plates with 2 x 10^  cells in 0.2 ml of 
culture medium/well. Culture medium consisted of RPMI medium-1640 
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containing 15% heat-inactivated fetal bovine serum (Flow Laboratories, 
McLean, VA) and 1% antibiotic-antimyco'tic solution (Glbco, Grand Island, 
NY). Unstimulated and mitogen stimulated cultures were assayed in 
triplicate. The mitogen used was phytohemagglutinin-P (PHA), which was 
purchased from Difco Laboratories, Detroit, MI. Metabolites were added 
to each well in 25 ul aliquots. The final concentration of each 
metabolite in the well was 0 (control), 1.0 or 10 mM. Leu 
concentrations, however, were slightly higher since RPMI medium-1640 
contains approximately 0.38 mM Leu. Microtiter plates were incubated at 
37° C In a humidified 5% COg atmosphere. After 48 h, 0.25 uCl of ^ H-
thymldine (New England Nuclear, Boston, MA) was added to each well. 
Eighteen h later, the cultures were harvested onto glass-fiber filters 
with an automated sample harvester (Cambridge Technology, Watertown, 
MA), filters were placed in 10 ml Sclntlverse scintillation solution 
(Fisher Scientific, Springfield, NJ) and radioactivity was counted in a 
liquid scintillation counter. 
Leucine and Leucine Metabolites. Figure 1 Illustrates the metabolic 
pathway of Leu Including only the Leu metabolites used in this study. 
Metabolites were prepared in RPMI medium-1640. The 1-Leu, IVA, HMG, dl-
fiOHB, n-butyrate, AcAc, dl-AOHB, GOHB and dl-AOHI were purchased from 
Sigma Chemical Company, St. Louis, MO. Acetate and acetone were 
purchased from Fisher Scientific, Springfield, NJ and the (s)-(+)-Cit 
was purchased from Aldrich Chemical Co., Milwakee, WI. The KIC was 
purchased from SOBAC, Paris, France and the HMB was synthesized in our 
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laboratory (Coffman et al., 1957) and the resulting calcium salt was 
purified by crystallization in 95% ethanol. The calcium salt was 
converted to a sodium salt form and used in subsequent assays. Purified 
HMB was derivatlzed with N-methyl-N-(t-butyldimethylsilyl) 
trifluoroacetamide (Regis Chemical Company, Morton Grove, IL) and 
analyzed by gas chromatography/mass spectrometry. The pattern of 
fragmentation indicated HMB to be the major product. High performance 
liquid chromatography indicated the purity of this compound to be 
greater than 90%. All metabolites were purchased or prepared in the 
form of sodium salts except the AcÂc which was purchased as a lithium 
salt. Since lithium has been shown to augment lymphocyte proliferation 
(Gelfand et al., 1980) the AcAc was converted to the sodium salt form 
using a cation exchange resin (Sigma Chemical Co., St. Louis, MO). The 
pH of all metabolites was adjusted to approximately 7.3. Metabolites 
were passed through a 0.2 um acrodlsc filter assembly (Ann Arbor, MI) to 
assure sterility. 
Dose Response Curves. The sodium salt forms of HMB and BOHB were 
diluted with RFMI medium-1640 so that the final concentration of each 
metabolite in the lymphocyte culture would be 0, .0001, .001, .010, 
.100, 1.0, 10.0 mM. Twenty five ul allquots were added to the 
appropriate wells. Quadruplicate wells were set up for each metabolite 
at each concentration. 
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Statistical Analysis. The experimental results are expressed as the 
percent change from the control ± standard error (SE). The percent 
change was calculated from each assay and the mean percent change Is 
reported. The significance of the changes was determined by student's 
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Figure 1. The metabolic pathway of leucine (including only the 
metabolites used in this stud^). 
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RESULTS 
The results for the mitogen stimulated blastogenesls assays are 
shown In Table 1. The PHA-stimulated blastogenlc response for 
lymphocytes cultured In the absence of metabolites was 29212 + 2324 
counts per mln per 200,000 lymphocytes. When Leu was added to 
lymphocytes, a decrease In lymphocyte blastogenesls of approximately 25% 
was observed at 10 mM Leu when compared to the control value. The next 
two metabolites In the Leu pathway, KIC and IVA, did not alter the 
mltogenlc stimulation. AcAc also did not significantly alter 
blastogenlc responses. The addition of acetate and HMG at 10 mM 
significantly Increased blastogenesls while acetone did not alter 
blastogenesls. BOHB and HMB also significantly Increased blastogenesls 
at both 1 and 10 mM with HMB being approximately 2 fold as active as 
BOHB, Unstimulated lymphocytes cultured In the presence of each 
metabolite followed the same trends as those lymphocytes cultured with 
PHA. HMB and BOHB enhanced unstimulated blastogenlc responses by 70 and 
30 % respectively. These results, however, were not significant due to 
the large day to day variations. 
The dose response curve for HMB and BOHB Is shown In Figure 2. 
Both metabolites Increase blastogenesls, again, HMB Increased responses 
approximately 50% more than BOHB at all concentrations. When evaluating 
the mltogenlc stimulatory responses for both compounds, the greatest 
percent change from the control occurred between 1 and 10 uM. Blastogenesls 
did, however, slightly Increase continually as the concentration of each 
metabolite Increased. 
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The Incubation of lymphocytes with PHA and the other hydroxy acid 
compounds (ÂOHB, GOHB, Â0H1 and Clt) at concentrations of 1 and 10 mM 
did not significantly alter blastogenlc responses and, In most Instances 
tended to decrease lymphocyte transformation by approximately 3-7% (data 
not shown). 
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Table 1. Effect of addition of Leu and Leu metabolites to PHA-
stlmulated cultures of normal ovine lymphocytes 
Metabolite Concentration Percent change P < Number of 
over control replicates 
± SE 
Leu 1 mM -12 ± 6 0.10 8 
10 mM -24 ± 5 0.01 8 
KIC 1 mM - 3 ± 7 0.60 8 
10 mM - 8 ± 12 0.60 8 
IVA 1 mM - 1 ± 9 1.00 6 
10 mM -17 ± 8 0.30 6 
HMB 1 mM +78 ± 13 0.01 13 
10 mM +91 + 12 0.01 13 
HMG 1 mM +28 + 9 0.20 6 
10 mM +46 + 11 0.01 6 
Butyrate 1 mM +52 ± 12 0.20 8 
10 mM -21 + 17 0.50 8 
Acetate 1 mM +22 + 7 0.50 4 
10 mM +47 ± 8 0.05 4 
Acetone 1 mM +31 + 9 0.60 4 
10 mM +27 ± 6 0.70 4 
AcAc 1 mM -6 + 9 0.70 6 
10 mM -14 + 11 0.50 6 
fiOHB 1 mM +25 + 6 0.01 15 
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Figure 2. The effect of ^ -hydroxy-;9-methyl butyrate (+) and 
-^hydroxybutyrate (•) at ten fold concentrations on the 
proliferation of FHA stimulated normal ovine lymphocytes 
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DISCUSSION 
Leu and KIC are metabolized following Ingestion, therefore, a direct 
effect of the compound or an Indirect effect of a metabolite of the 
compound on lymphocyte blastogenesls Is possible. From the present 
study. It Is clear that the stimulatory effect of KIC on lymphocyte 
blastogenesls Is not due directly to KIC Itself. However, findings from 
these studies suggest that a metabolite of KIC, HMB, which markedly 
stimulated blastogenesls may Indirectly be responsible for the effects 
of KIC seen In vivo. 
In the present study, HMG at the 10 mM concentration also stimulated 
blastogenesls. The metabolic relationship between KIC, HMB and HMG is 
not clear. KIC has been shown to be converted to HMB by the enzyme KIC 
oxygenase (Sabourln and Bleber, 1982). Thus, KIC could act in vivo via 
conversion to HMB. Older Isotopic studies, using paper and column 
chromatography, demonstrates that HMG and HMB can be Interconverted in 
vivo (Adamson and Greenberg, 1957). This supports the present study in 
which high concentrations of HMG enhanced lymphocyte blastogenesls. 
More recent literature in which newer methodology was used, however, 
does not mention this metabolic interconversion. Thus, it is unclear if 
a relationship exists in vivo. Assuming the most potent metabolite is 
the bioactive compound, then HMB is the product stimulating 
blastogenesls in vitro and in vivo. Other stimulators such as BOHB, 
acetate and HMG may directly affect blastogenesls or may be converted to 
HMB and have an indirect effect on blastogenesls. 
In the present study, Leu significantly suppressed lymphocyte 
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blastogenesls when added to FHÂ stimulated lymphocytes at a final 
concentration of 10 mM. It seems that the suppressive effect of Leu 
on immune function in vivo could, therefore, be due to a direct effect of 
Leu on lymphocyte function. Further studies will be necessary to 
document the importance of this observation and its relationship to Leu 
nutrition. 
Although most metabolites of Leu have not been examined relative to 
blastogenesis, suppression of lymphocyte blastogenesis has been 
demonstrated (Targowski and Klucinski, 1983) when BOHB was added to 
bovine lymphocyte cultures at similar concentrations (.01 - .5 mM). The 
culture medium used in the studies with bovine lymphocytes was Eagle's 
minimal essential medium supplemented with 0.1% fetal bovine serum. In 
the present study, RPMI medium-1640 supplemented with 15% fetal bovine 
serum was used as the culture media for the ovine lymphocytes. RPMI 
medium-1640 contains approximately .38mM Leu while Eagle's media 
contains twice this much Leu which could interact with BOHB effects. 
The other possible explaination for the discrepancies between studies 
could be the amount of fetal bovine serum used. In the study with the 
bovine lymphocytes, only 0.1% fetal bovine serum was used and no 
enhancement was seen with the addition of any metabolite tested 
(butyrate, acetone, AcAc, BOHB). In the present study, 15% fetal bovine 
serum was used and enhancement, suppression and no effect were seen with 
the addition of metabolites. The BOHB used in both studies was dl-BOHB. 
Since the d isomer is the natural metabolite, it is unknown whether the 
1 isomer is inert or if it affects metabolism. 
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Both HMB and BOHB stimulated blastogenesls at .1 uM, although 
blastogenlc responses tended to Increase as the concentration of each 
metabolite Increased. The stimulatory effects of these two hydroxy 
acids are not common to all hydroxy acids because AOHB, GOHB, AOHI and 
Clt did not alter blastogenesls. It, therefore, seems that HMB and 
possibly BOHB may have specific direct effects on lymphocyte 
blastogenesls. 
In conclusion, the stimulatory effects of KIC on lymphocyte 
blastogenesls in vivo can not be explained by a direct effect in vitro. 
However, the production of a specific hydroxy acid metabolite, HMB, 
could be reponsible for the observed effects. Conversely, 
the suppression effects of Leu on blastogenesls and Immune response in 
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The major findings from these experiments are that: (1) the oral 
administration of leucine (Leu) and a-ketoisocaproate (KIC) to sheep 
affect lymphocyte blastogenesis in opposing manners and that these 
effects are associated with alterations in the ratios of specific 
circulating T-cell subsets; (2) the effects exerted by Leu on lymphocyte 
blastogenesis may be caused by a direct effect of Leu on lymphocyte 
blastogenesis while the effects exerted by KIC could be due to another 
Leu metabolite, /9-hydroxy-/9-methylbutyrate (HMB) ; and (3) KIC 
partially overcomes the adverse effects of ACTH-induced 
immunosuppression in sheep. 
When evaluating the possible mechanism of Leu and KIC on 
immune function, the effects of these compounds on T-cell subsets must 
be given foremost consideration since alterations in T-cell subsets have 
been shown to be associated with a variety of disease and 
Immunodeficiency states. KIC has been shown to increase the percentage 
of circulating T4 cells when orally administered. This could explain 
the enhancement that KIC exerts on lymphocyte blastogenesis and the 
positive effects that KIC also exerts on ACTH-induced immunosuppression 
in sheep. However, the in vitro addition of KIC to mitogen-stimulated 
lymphocyte blastogenesis did not cause enhancement. Another metabolite 
of KIC, HMB, enhanced mitogen-stimulated lymphocyte blastogenesis by 
100% when added to lymphocyte cultures in vitro. Two other metabolites 
of Leu also enhanced blastogenic responses. These metabolites were 
/9-hydroxy-^ -methylglutarate (HHG) and ^ -hydroxybutyrate (BOHB). Both 
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of these metabolites, however, enhanced the blastogenesls to a much 
lesser degree than HMB. It has, therefore, been concluded that the 
effect which KIC exerts on Immune function In sheep, both In vitro and 
In vivo, Is due to the further catabollsm of KIC to HMB. KIC has been 
shown to be converted to HMB by the enzyme, KIC oxygenase. BOHB and HMG 
may also be converted to HMB and, therefore, the In vitro addition of 
these compounds also resulted in enhanced blastogenlc responses. 
Leu suppresses lymphocyte blastogenesls both In vivo and In 
vitro. It has, therefore, been concluded that the effects which Leu 
exerts on Immune function Is due to a direct effect of Leu and not to 
further catabollsm of this compound. Leu has been shown to decrease the 
percentage of circulating T19 lymphocytes and this may explain the 
Immunosuppressive effects seen with the oral supplementation of Leu. 
It could be argued that since HMB, HMG and BOHB are hydroxy-acIds, 
-^oxidation of these compounds may occur during lymphocyte transformation 
and the energy equivalent formed may be responsible for the Increase in 
lymphocyte blastogenesls. However, the data from the current research 
indicate that this is not so. First of all, other hydroxy-acids were 
added to lymphocyte cultures and they did not effect lymphocyte 
blastogenesls. Secondly, other compounds tested In this research 
(butyrate and acetoacetate), which could alter lymphocyte blastogenesls 
due to their associated energy effects, did not significantly alter 
lymphocyte blastogenesls. This supports the contention that the actions 
of HMB, HMG and BOHB were not due to energy alterations by these 
compounds. Therefore, the actions of KIC, in vivo, on lymphocyte 
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blastogenesis must be due to an Indirect effect of HMB not to KIC 
directly. 
Conclusions drawn from these experiments are based on two separate 
in vitro lymphocyte assays. Although these assays have substantial 
validity, several problems exist with in vitro cell assays. Some of 
these problems involve sample collection, cell separation, culture 
methods, the standardization of cell numbers and the variation between 
animals. In turn, these minor problems make it much more difficult to 
extrapolate in vitro and in vivo cellular immune response to animal 
health response. 
Peripheral blood samples were used in all T-cell evaluations 
reported here. It is, however, important to note that the relative 
proportions and functional behavior of T-cells from different lymphoid 
tissues vary, and normal controls established for peripheral blood 
lymphocytes may be not applicable to other lymphocyte populations. 
Blood samples were collected in the morning, prior to feeding which 
could affect the number and relative proportions of circulating 
lymphocytes due to the diurnal patterns of some hormones and circulation 
patterns of lymhpocytes. In addition to animal variation, the physical 
method of separation may also vary. Lymphocytes were isolated using 
Sepracell-MN, a colloidal silica based medium, which works on a 
continuous density gradient system by centrifugation. When comparing 
this method with other separation techniques such as Ficoll-Hypaque, 
this method was perferred. No layering of the blood over the gradient 
was necessary, a larger number of lymphocytes containing a low 
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percentage of monocytes (1-2%) were recovered and there was very little 
red blood cell contamination. This is important because erythrocyte 
aggregation polymers have been shown to decrease mitogen responsiveness 
of isolated lymphocyte preparations. 
The in vitro stimulation of lymphocytes by specific mitogens has 
become one of the most widely used screening assays for cellular immune 
responsiveness. This assay was used in the current research as an 
indicator of lymphocyte function. A medium was selected which contained 
a relatively low concentration (0.38 mM) of Leu since Leu was a variable 
studied in the reported experiments. It is necessary to supplement 
cultures with animal serum for maximal lymphocyte transformation and 
cell viability. Fetal bovine serum was added in these ovine cell 
cultures since it was commercially available and since fetal ovine serum 
could not be obtained. An electronic cell counter was used to 
standardize cell numbers and an electronic pipette was used to plate the 
cell suspensions to increase the accuracy of pipetting. Initially, a 
dose response curve was constructed for each mitogen so that the proper 
amount of each mitogen necessary for maximum stimulation could be 
3 determined. Lymphocytes were cultured in the presence of H-thymidine 
3 for 18 hours. Since exposure to H-thymidine at very high levels is 
3 detrimental to cell growth, cells were incubated with low levels of H-
thymidine for a relatively long period of time (18 hours) to minimize 
DNA damage. Also, the 18 hour Incubation period provided enough time 
for all lymphocytes to divide. 
To evaluate T-lymphocyte subset percentages, monoclonal 
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antibodies directed against specific T-lymphocyte surface receptors were 
used. Again, the problems associated with in vitro cell assays were 
encountered here. Since no total blood lymphocyte counts were taken, 
only the percentages of each subset could be reported which did not 
allow for any changes In total lymphocyte numbers to be quantltated. An 
additional problem encountered in evaluating T-cell subsets, was the 
interpretation of the T19 cell-type histograms. For all other 
monoclonal antibodies used, peaks obtained were clearly defined and 
Integrated. However, histograms obtained from T19 cell subsets were 
somewhat broad and not easily defined (see Appendix E). The most 
significant problem was encountered when trying to determine where the 
negative control range ended and the T19 range began. It may be that 
the maturing T19 cell may bear two distinct phenotypes which may have 
different levels of receptors or may have different receptor binding 
affinities. Either of these possibilities could lead to a broad peak 
range on the histogram. All histogram peak ranges obtained from the use 
of these sheep monoclonal antibodies were, however, repeatable between 
animals and weeks. 
While the mechanisms are not entirely clear, it is evident that Leu 
and KIC exerted opposing effects on immune function in sheep. Both 
these compounds can modulate immune function when fed in relatively 
small quantities (0.1% of the diet). Leu has been shown to also alter 
immune parameters In non-ruminants when fed In much higher amounts. The 
difference in amounts needed to elicit these responses may be partially 
explained by the fact that ruminants have lower concentrations of the 
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enzymes necessary to metabolize these compounds. The fact that these 
enzyme concentrations are lower In ruminants may be related to the fact 
that sheep and cattle are primarily grazing animals. Most forages 
contain relatively low Leu as compared to grains. Cattle and sheep 
therefore, may have not had to adapt to metabolizing large amounts of 
Leu. These relatively low enzyme concentrations would then be a type of 
an "adaptation mechanism" developed throughout evolution. 
Domestication and intensification of modern day farm management 
practices can stress animals and this in turn can result in disease 
outbreak. Thus, a role for immunomodulators in livestock practices 
becomes more important as these practices intensify further. The 
observation that KIC improves Immune function in sheep suggests that 
supplementation could augment the Immune system during the stressful 
times of weaning, handling, transport, castration and parturition. This 
in turn, has the potential for economic returns by the sheep producer. 
Further studies will be necessary to determine if beneficial effects of 
KIC are manifest in field "disease" states. 
The immunosuppressive effect of small amounts of Leu is surprising. 
It is hard to imagine that the supplementation of 1 g of Leu a day in 
addition to the 10 g normally absorbed could adversely affect immune 
function. Again, the marginal degradation pathways of Leu in the gut 
and liver of sheep may result in direct immunosuppressive effects ln~gut~ 
and liver associated lymphoid tissues. The practical implication of 
this is unknown but could be of Importance. For example, if Leu is 
Immunosuppressive, it may be of Importance to use a feedstuff containing 
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relatively low amounts of Leu when weaning, transporting or handling 
animals. Our domestication practices have taken grazing livestock and 
subjected them to stressful handling and housing conditions. Currently 
In the United States, these grazing species are given high corn 
containing diets and corn is high in Leu. This may be a contributing 
factor in the large economical losses of animals observed in our current 
livestock production practices. 
There is still much to learn about the use of KIC and Leu in 
ruminant animals. One of the foremost questions to be answered is: Does 
the feeding of the apparent active metabolite of KIC, HMB, have any 
affect on the Immune system? In any event, the addition or depletion of 
nutrients and/or additives which enhance the Immune system of ruminants 
is certainly warranted so that livestock can better adapt to stressors 
of modern day production systems. Immunomodulators can then be adjuncts 
to the homeostasis mechanism. 
"All the vital mechanisms, varied as they are, have only one object, 
that of preserving constant the conditions of life in the Internal 
environment." -Claude Bernard, 1878. 
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APPENDIX A 
Isolation of Ovine Mononuclear Cells Using Sepracell-MN 
Use aseptic techniques. 
1. Collect 50 ml of whole blood using a sterile 60 ml syringe and 14 
gauge (1.5 inch) needle filled with 10 ml 2 X ACD (acid-citrate-dextrose) 
solution. Transfer to a sterile 50 ml conical centrifuge tube. Mix 
well after collection. 
2 X ACD: 
22.0 g trisodium citrate 
8.0 g citric acid 
25.0 g dextrose 
500.0 ml distilled water 
(Filter sterilize using a .22 micron disposable sterile 
filter system) 
2. Centrifuge at lOOOg for 25 minutes. 
3. Transfer 3 ml buffy coat and 1.5 ml plasma (use a 5 ml sterile glass 
volumetric pipet) into a 15 ml centrifuge tube containing 6 ml 
Sepracell-MN (Sepratech Corporation, Oklahoma City, OK). Mix well. 
4. Centrifuge at 1500g for 25 minutes. 
5. Aspirate mononuclear cell layer (using a 1 ml sterile glass 
volumetric pipet) and transfer to a sterile, 25 ml glass tube 
++ 
containing 10 ml Hank's Balance Salt Solution without Ca or 
1-4-
Mg (HBSS; Gibco, Grand Island, NY) or phosphate buffered saline 
(PBS) which has been warmed in a 37° C water bath. Rinse the pipet 
with the HBSS to get all cells. Invert to suspend cells. 
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Phosphate buffered saline: 
16.5 ml solution A 
33.5 ml solution B 
8.0 g sodium chloride 
Solution A: 2.76 g/10 ml NaHgPO^ 'HgO 
Solution B: 5.37 g/10 ml NagHPO^ H^gO 
(Filter sterilize) 
6. Spin at 150g for 15 minutes. 
7. Decant supernatant carefully (cells don't stick well at this stage) 
and resuspend in 10 ml HBSS or PBS. 
8. Spin at 300g for 10 minutes. 
9. Decant supernatant and resuspend in 1 ml HBSS or PBS (if large 
pellet, may want to use more HBSS to resuspend). 
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APPENDIX B 
Isolation of Ovine Mononuclear Cells Using Hlstopaque-1077 
Use aseptic techniques. 
1. Collect blood In same manner as stated in appendix A. 
2. Remove buffy coat and dilute 1:2 with HBSS or PBS. Mix by gently 
inverting. 
3. Layer 10 ml of diluted buffy coat on 6 ml Hlstopaque-1077 (Sigma 
Chemical Co., St. Louis, MO) which has been previously pipetted 
into 25 ml sterile centrifuge tubes. 
4. Centrifuge at 400g for for 30 minutes. 
5. Remove lymphocyte band and transfer to another sterile 25 ml tube. 
6. Wash cells with HBSS or PBS as in Sepracell-MN separation method. 
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APPENDIX C 
Outline for a 3-day Lymphocyte Blastogenesls Culture 
Use aseptic procedures and keep all reagents at 37° C in a water bath. 
1. Transfer approximately 0.1 ml of isolated lymphocytes in HBSS or PBS 
(use above procedures for isolation of lymphocytes) into a glass 12 
X 75 mm tube. 
2. Count each sample in glass tube on automated cell counter (Coulter 
Electronics, Hialeah, FA). Multiply each count from the Coulter 
3 
counter by 10 to obtain the number of cells per ml. 
Example: Count from Coulter - 7500. Therefore the number of 
cells/ml - 7.5 x 10^  x 10^  - 7.5 x 10*. 
3. Calculate the amount of cells needed. Need 2 x 10^  cells per well. 
If you were to set up one row for each animal: (2 x 10^  cells/well) 
(12 wells) - 2.4x 10* cells required from each animal. 
4. Calculate the total volume required. Use 200 ul/well. So: (0.2 
ml/well) (12 wells) - 2.4 mis minimum needed. Add approximately 0.4 
mis extra, so need 2.8 mis. 
5. prepare medium. 
RPMI-1640 + 15% Fetal calf serum + 1% Penn strep + 1% Fungizone. 
(RPMI: Gibco, Grand Island NY; Fetal calf serum: Flow Labs Inc., 
McLean, VA and Antibiotic/antimycotic: Sigma Chemical Co., St. 
Louis, MO). Fetal calf serum is heated at 56° for 30 minutes and 
diluted 1:4 with medium prior to use. 
6. Calculate the amount of cell suspension you need to add to medium to 
get final concentration. 
Example: Count from one animal 10 x 10^  cells/ml and you want to set 
up one row, to calculate: 
2.4/10 - ,24 - 2.8 - 2.56 
Cells needed divided by cells/ml equals ml of cell suspension you 
need to add to medium for final concentration. Subtract that amount from 
total volume desired to arrive at the amount of medium you need to mix up 
for that animal. 
7. First mix up the medium solution in a tube or bottle. Add the 
appropriate amount of medium solution to a 12 x 75 mm snap-cap tube 
for each sample. Next, add the necesary amount of cell 
suspension from each animals into the appropriate tubes. Add one 
animal's cell at a time, gently Invert tube to mix and then transfer 
0.2 ml of suspension into each well. 
8. After the cell suspensions have been added to the plates, the 
various mitogens are added to the wells. Fhytohemmagglutin-P (FHA; 
Dlfco Labs, Detriot, MI) and added at a dilution of 1:100 prepared 
with medium; ConcanavalinA (ConA; Miles Labs, Elkhart, IN) was 
diluted 1:200 and Pokeweed mitogen (PWM; Glbco, Grand Island, NY) 
was diluted 1:10. Do each In triplicate. Add allquots of 25 ul. 
Add 25 ul of medium to control plates to keep volume constant. 
9. Place plates at 37 ° C In a humidified 5% COg atmosphere for 
approimately 48 hr. 
3  10. Add .25 uCi of H-thymidine (New England Nuclear, Boston, MA) to 
each well. Place back in incubator for approximately 18-20 hr. 
11. Harvest cells with an automated cell harvester (Flow Laboratories, 
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McLean, VA), place filter pads in scintillation vials, add 10 ml 
CytoScint scintillation solution (ICN Biomedicals, Irvine, CA) and 
count for four minutes each. 
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APPENDIX D 
Procedures for use of SBU-Tl, SBU-T4, SBU-T8 and SBU-T19 Monoclonal 
Antibodies with Isolated Ovine Peripheral Lymphocytes 
Keep all reagents Ice cold. 
1. Isolation ovine peripheral blood lymphocytes using above isolation 
procedures (The author's experiences show that Sepracell-MN works 
best since no red blood cell contamination is apparent). If red 
blood cells are a problem use the following solution; 
Red blood cell Ivsts solution: 
8.3 g ammonium chloride 
.037 g EDTA 
1.0 g Potassium Bicarbonate 
per 1.00 1 triple distilled water 
pH - 7.2 
Keep ice cold, use 1:1 with whole blood, gently invert until a 
color change is seen, centrifuge at 400g for 15 minutes, decant and 
wash white blood cell pellet three times with ice cold PBS/Az. 
2. Count cells on a automated cell counter (Coulter Counter 
Electronics Hialeah, FA). 
3. Adjust concentration with PBS containing 0.1% sodium azide (PBS/Az) 
and 0.5% BSA so that 1 x 10^  cells/well can be plated in 50 ul of 
PBS/Az. 
4. Plate enough cells so that each monoclonal can be done in duplicate. 
Use U-bottom microtiter plates. Prepare enough wells so that cells 
can be incubated with first and second antibodies only. 
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Prepared monoclonal antibody supernatant as directed by adding 5 ml 
distilled water (Dr. M.R. Brandon,'University of Melbourne, 
Parkville, Victoria, Australia). 
Add 50 ul of appropriate supernatant to each well and incubate at 
4°C for 30 minutes. 
Wash cells twice with PBS/Az by centrifuging at 300 x g for 15 
minutes. 
Incubate cells for 30 minutes at 4^ 0 with 40 ul of a 1:10 dilution 
of a fluorescelnisothiocyanate (FITC)-conjugated rabbit FCab')^  
anti-mouse immunoglobulin (DAKO Corporation, Carpinteria, CA). 
Cover plates with aluminum foil so that no light can exhaust the 
fluorescence. 
Wash cells 3 times with PBS/Az. 
Resuspend in 200 ul if cells are to be run immediately, if not, 
resuspend in 200 ul 1% formalin (Electron Microscopy Sciences, Fort 
Washington, PA) and store at 4°C overnight. Centrifuge and 
resuspend in PBS/Az prior to sorting. 
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APPENDIX E 
Cytofluorographlc Analysis Used In the Analysis of Ovine T-cell Monoclonal 
Antibodies 
An EPICS 752 flow cytometer (Coulter Electronics, Hlaleah, FA) was 
used for detection of fluorescent stained cell. Cells were excited at 
488 mo. Light passing to the fluorescence detector was split using a 488 
nm dlchrolc filter. Fluorescence was collected through a 515 long pass 
filter and the presence or absence of a range of cell surface markers 
was determined. Only those cells containing the lymphocyte populations 
Indicated by forward angle light scatter and 90° light scatter 
histograms were analyzed for fluorescence using the EASY88 computer 
system with Intgra software (Coulter Electronics, Hlaleah, FA). A 
minimum of ten thousand events were collected per sample. Monocytes 
and debris were excluded by gating out on the basis of forward angle 
light scatter and 90° light scatter. 
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Figure 1, Two dlmenalonal flo# cytometric analysis of sheep peripheral 
blood lymphocytes labelled with the monoclonal antibodies SBU-Tl, SBU-
T4, SBU-T8 and SBU-T19, Sheep lymphocytes were reacted with monoclonal 
antibody supernatant and then with FITC-rabbit anti-mouse IgO. 
Fluorescence intensity is plotted on the X axis in arbitary units and 
cell frequency on the Y axis. The controls for each cell type consists 
of PDS/Az followed by FITC-conJugated second antibody and in each case 
shows only negligible fluorescence. Profiles are (a) control; (b) SBU-
Tl; (c) SBU-T4; (d) SBU-T8, and <e) SBU-T19. 
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Figure 2. Three dimensional flow cytometric analysis of sheep 
peripheral blood lymphocytes labelled with the monoclonal antibodies 
SBU-Tl, SBII-T4, SBU-T8 and SBU-T19. Sheep lymphocytes were reacted with 
monoclonal antibody supernatant and then with FITC-rabbit anti-mouse 
IgG. Forward angle light scatter as a relation to cell size is plotted 
on the X axis in arbitary units, relative fluorescence is plotted on the 
Y axis and relative cell number on the Z axis. The controls for each 
cell type consists of PBS/Az followed by FITC-conJugated second antibody 
and in each case shows only negligible fluorescence. Profiles are (a) 
control; (b) SfiU-Tl; (c) SBU-T4; (d) SBU-T8, and (e) SBU-T19. 
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APPENDIX F 
Outline of ^ -Hydroxy-/9-MethylButyrate Analysis by Gas 
Chromatograph/Mass Spectrometry (GC/MS) and Data Collected 
1. Add sample (1 ml plasma or 1 ml standard) + 50 ul internal standard 
to a 50 ml glass culture tube. 
Internal Standard 
9 5 ul D /8-hydroxy-)9-raethylbutyrate 
75 ml triple distilled water 
2. Adjust pH < 2.0 with 3N HCl using pH paper. Vortex. 
3. Add 30 ml diethyl ether (Fisher Scientific Co., Fair Lawn, NJ). 
4. Vortex and centrifuge at 425g for 10 minutes. 
5. Remove as much water layer as possible by aspirating. 
6. Place culture tube into liquid nitrogen , placing tube at a depth 
just beyond the water layer, submerge until water layer and 
plasma proteins are frozen. 
7. Transfer diethyl ether layer into a clean culture tube. 
8. Add 1 ml O.OIM phosphate buffer, adjust pH ~ 7.0. 
O.OIM Phosphate Buffer 
0.68 ml phosphoric acid/1 distilled water 
Adjust pH ~ 7.0 with sodium hydroxide 
9. Vortex and centrifuge at 425g for 10 min. 
10. Transfer buffer layer at the bottom of the tube into a dram vial, 
allowing no ether to contaminate sample in vial. 
11. Dry sample under nitrogen gas at 60 ° C. 
12. Add 100 ul of methylene chloride (Fisher Scientific Co., Fair Lawn, 
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NJ) to vial, dry under nitrogen gas at 60 ° C. Repeat two more 
times. 
13. Derivatize with 100 ul acetonitile (Regis Chemical Co., Morton 
Grove, IL) and 100 ul N-Methyl-N-(t-Butyldimethylsilyl) 
trifluoroacetamide (Regis Chemical Co., Morton Grove, IL). 
14. Sonicate for 1 minute, then vortex thoroughly. 
15. Heat for 1 hr at 60° C. 
16. Transfer into GC/MS vials and inject into gas chromatograph/mass 
spectrometer (Hewlett-Packard 5890/5790a using DATA:HMBSIM.M, which 
monitors 175, 178 and 183 AMU with injector @ 230 ° C and detector 
@ 285° C, and oven initially at 50° C. (îven temperature initial 
temperature at 50° C, ramp 1 at 20° C/min to 170°, hold for 0 
min., and ramp 2 at 50°/min to 270° C, hold for 0 min. Retention 
time is roughly 5.5 min. Column is 25m x .22 mm i.d. x .11 um film 
thickness, crosslinked silicone gum phase capillary column (HP-1, 
Hewlett-Packard, Avondale, PN). 
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Figure 1. Selected Ion monitoring (SIM) chromatographs of 
/3 - hydroxy-/3-me thy Ibuty rate with a Hewlett-Packard 5790a 
mass selective detector monitoring for masses 175, 178 and 
183 AMU as described in the outline above 
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APPENDIX G 
Plasma ^ -Hydroxy-^ -MethylButyrate Concentrations Following Oral 
Supplementation of a-Ketolsocaproate In Sheep 
Plasma samples were collected from sheep fed control, KIC or Leu 
supplemented diets for approximately 60 days in Experiments 1 and 2. 
GC/MS analysis was performed (see appendix F) to determine HMB 
concentrations. 
B-Hydroxy-B-methvlbutvrate 
(Mean of 2 experiments) 
(uM) ± SEM 
18.91 ± 4.49 
31.86 ± 4.64 




KIC fed animals had higher plasma HMB concentrations than Leu fed or 
control animals. This difference was significant only in the first 
experiment (P < 0.05). A large difference existed in the values 
collected for HMB concentrations of the animals between the 2 
experiments. This difference may be partially explained by the 
different genders of the animals or by the different environmental 
temperatures during the 2 experiments. However, the oral administration 
of KIC to sheep for 60 days results in elevated plasma HMB 
concentrations. 

